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The Rockefeller Foundation’s Disease Surveillance Networks (DSN) Initiative was launched in 2007 under the new Strategy framework of the
Foundation with the objectives of:
[1] Improving human resources for disease surveillance in developing 
countries, thus bolstering national capacity to monitor, report, and
respond to outbreaks;
[2] Supporting regional networks to promote collaboration in disease 
surveillance and response across countries; and 
[3] Building bridges between regional and global monitoring efforts.
In August 2009-2010 an independent external evaluation of the DSN Initiative
was undertaken in three parts: in Asia, Africa, and at a global level. This report
presents the results of the Global Evaluation which had the following objectives:
[1] To assess the relevance, effectiveness, efficiency, impact and sustainability
of the Rockefeller Foundation’s support to the DSN Initiative.
[2] To assess the underlying hypothesis of the DSN Initiative, that robust
trans-boundary, multi-sectoral and cross-disciplinary collaborative net-
works lead to improved disease surveillance and response. 
[3] To make forward looking recommendations to the Foundation on 1) the
implications of the achievements, challenges and lessons from the DSN
Initiative for the strategy and investments of the Rockefeller Foundation
at a global and regional level; 2) priority linkages and synergies for DSN
learning to benefit the work of other Rockefeller Foundation initiatives,
regional offices, and key partners; 3) key priorities for funding and part-
nerships to sustain the gains made by the Foundation in the field of dis-
ease surveillance networks; and 4) other implications as identified. 
[4] To contribute to the field of philanthropy by emphasizing the use of evalua-
tion in grantmaking and by informing the field of development evaluation
and assessment about methods and models to measure complex networks. 
The DSN Initiative has five outcome areas:
[1] Networks: Trans-boundary disease surveillance networks in Southeast
Asia and in Eastern and Southern Africa are formed, sustained, and
evolved to enable disease surveillance practitioners to collaborate, share
information, and learn how to more effectively address disease threats.
[2] Capacity: Disease surveillance practitioners and their institutions
strengthen, apply, and distribute technical and communication skills in
disease surveillance to more effectively address disease threats.
[3] Tools: Disease surveillance practitioners have increased access to and the
use of improved tools and methods to effectively and efficiently monitor,
share, and report information, and to respond to disease threats.
Executive Summary
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[4] Transdisciplinary Leadership in One Health: Policymakers, human
health, and veterinary practitioners take a transdisciplinary approach to
policy and practice in animal and human health, emphasizing the One
Health principles at the global, regional, and local levels.
[5] Organizational Excellence, Accountability, and Learning: The DSN
Initiative team operates effectively and efficiently, provides leadership in
the Rockefeller Foundation, contributes to the Foundation’s mission, is
relevant and accountable to its stakeholders, and learns from its monitor-
ing and evaluation. 
Based on feedback by grantees, stakeholders, field interviews, and desk studies,
the Global Evaluation Team found that the DSN Initiative achieved these out-
comes to a moderate or great extent. The hypothesis of the Initiative was gener-
ally supported by global and regional data, showing that robust trans-boundary,
multi-sectoral/cross-disciplinary collaborative networks lead to improved dis-
ease surveillance and response. This is more systematically addressed in the
regional reports covering specific outbreak responses and joint exercises. 
The major contributions of the DSN Initiative to global health were found
to be the fostering of the new fields of One Health and Global Health
Diplomacy; use of informal networks in surveillance; and transnational 
collaboration and governance. 
Stakeholders at global, regional and national levels validated the relevance of
a networked approach to disease surveillance, and supported the concept,
rational and logic underlying the DSN Initiative. The DSN Initiative was
seen by stakeholders and influential leaders as an effective way of building
trust among partners in historically unstable regions, and contributed to
increases in capacity through training, tools, and technical support. 
The evaluation found that grantees at the global level are showing good signs of
sustainability by leveraging the funds of the Foundation to attract other donors.
While the data indicates that many of the DSN Initiative activities and concepts
are taking root globally and regionally, there is a risk that winding down support
to the emerging fields of One Health and Global Health Diplomacy may leave
them without much needed support at this stage of their development. 
A major dimension of sustainability is the ability to achieve and sustain the
profile of new ideas and practice. The evaluation noted that the DSN Initia-
tive grantees in Asia and Africa do not write and publish their work as much
as would be expected and needed to maintain and grow a new field. The
Global Evaluation Team encourages the Foundation to emphasize the need
for grantees to publish their work in peer-reviewed literature to enhance the
work’s influence in health and policy fields. 
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The effectiveness of Foundation management of the DSN Initiative was eval-
uated within the limitations of available data. The evaluation found a good
alignment of resources (staff, grant funding and non-grant activity) to the
outcome areas and strategy of the DSN Initiative throughout the course of
the initiative. Changes in management of the DSN Initiative, however,
affected the continuity and consistency of grantees’ relationships. Changes
also limited the synergies across Rockefeller Foundation initiative portfolios.
For more effective ongoing management, the Global Evaluation Team encour-
ages the Foundation to improve the documentation and data capture of ini-
tiative work to include the use of benchmarks and indicators in the initial
review of proposals, improve documentation of changes to plans as work
evolves, and synergies between portfolios of work.
The breadth of the influence of the DSN Initiative beyond disease surveil-
lance warrants consideration of a new title for the body of work that reflects
the many contributions made to communities of practice. The evaluation
proposes “rebranding” some of the DSN Initiative work as Communities of
Transnational Public Health Policy and Practice, to better reflect an evolving
field going forward. 
The Global Evaluation makes the following recommendations:
[1] The Foundation should continue to invest in transnational strategies as
well as country-by-country strategies, as the two are not mutually exclu-
sive and with increasing globalization transnational investment is essen-
tial to successfully assure “smart” globalization.
[2] The DSN Initiative contributed to the development of network strate-
gies in climate change resilience and other areas of the Foundation’s
work. Elements of existing DSN networks should be considered as 
valuable Foundation (and stakeholder) assets to be fostered through
additional funding where needed, and to be extended to other portfolios
of investment. 
[3] Sustainability is the ultimate proof of added value, thus an exit strategy
for Foundation investment is of central importance. In particular foster-
ing thoughtful integration of key Mekong Basin Disease Surveillance
(MBDS) network elements with other efforts, such as the Association of
Southeast Asian Nations (ASEAN), Asia Pacific Strategy for Emerging
Infectious Disease (APSED), United States Agency for International
Development (USAID), Asia Development Bank (ADB) and US Centers
for Disease Control and Prevention (CDC), could help to assure popula-
tion security in the region for the longer term.
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[4] As investment in some outcome areas of the DSN Initiative portfolio con-
tinues, revisiting the portfolio for a definitive summative evaluation using
the tools and metrics developed in this global evaluation will be of added
value especially in the areas of One Health and global health diplomacy,
the establishment of the South Asia network, the maturation and evolu-
tion of governance of Connecting Health Organizations for Regional Dis-
ease Surveillance (CHORDS), the transfer of informatics capacity, and the
strategy for institutionalization and sustainability of the MBDS network.
[5] Given the South-South nature of collaborative networking efforts in 
the portfolio, a greater emphasis on bilateral South-South negotiations
within the emerging realm of global health diplomacy, and a more
robust effort at inclusion of diplomatic and scientific leaders from the
South will enhance the utility of this new field.
[6] Encourage and support publishing and communicating the work of the
DSN Initiative and grantees. While global health diplomacy has prolific
publications, in other areas of the DSN Initiative increased publications
from grantees both in the peer reviewed and non-peer reviewed literature
would enhance the visibility and influence of the work. 
[7] Landscaping for prospective Rockefeller Foundation initiatives should
include detailed identification of stakeholders and indicators as well as a
theory of change. In particular population health metrics should be iden-
tified and modeled to where impact is anticipated through investment. 
[8] The Foundation should make explicit the expected synergies among
grantees towards the common vision of portfolio. Convening grantees is
an important strategy in this regard. Experience with the DSN Initiative
suggests MBDS convening with other grantees during their sessions and
the initial Bellagio disease surveillance meeting was particularly fruitful
in this regard. Specific prospective network mapping and indicators
would assist this process. 
[9] While Disease Surveillance Networks has served as the title of this port-
folio in fact the work has created Communities of Transnational Public
Health Policy and Practice in two regions and globally. Re-branding this
effort more accurately is worthy of consideration. 
We would like to commend the Foundation’s efforts at building evaluation
capacity in developing countries, and internally at the Foundation. There are
considerable strides being made within the Foundation that will address the
challenges the DSN evaluators faced during the course of work, including
improving accessibility to records and reports, formalizing learning mecha-
nisms within the Foundation, operationalizing evaluation and learning, and
establishing metrics to aid in ascertaining impact of Foundation efforts.
The Global Evaluation Team
University of Washington
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1. Introduction and Objectives
In August 2009, the Rockefeller Foundation commissioned an independentexternal evaluation of the Disease Surveillance Networks (DSN) Initiative
in Asia, Africa, and globally. This report covers the results of the global 
component of the summative and prospective1 evaluation, which had the fol-
lowing objectives:
[1] Assessment of performance of the DSN Initiative, focused on its 
relevance, effectiveness/impact, and efficiency within the context of the
Foundation’s initiative support.
[2] Assessment of the DSN Initiative’s underlying hypothesis: robust 
trans-boundary, multi-sectoral/cross-disciplinary collaborative networks
lead to improved disease surveillance and response. 
[3] Assessment of the quality of Foundation management (value for money)
for the DSN Initiative.2
[4] Contribute to the field of philanthropy by:
a. Demonstrating the use of evaluations in grantmaking, learning and
knowledge management; and
b. Informing the field of development evaluation about methods and
models to measure complex networks.
While implicit in Objective 4a and 4b above, it should be noted that the
evaluation was also framed as a learning exercise for its participants. In par-
ticular, an outcome of the evaluation is the demonstration of excellence and
capacity in developing country evaluation partners to carry out such work.
1 It should be noted that many of the grants in the DSN/PAN (Pandemics) portfolio are
in early phase or mid-course, thus an iterative rather than summative evaluation has been
carried out. 
2 This evaluation did not include formal financial or economic analyses, only general
observations based on performance for cost. 
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2. Context of the DSN Initiative
The DSN Initiative portfolio of grants for this evaluation consisted ofgrants awarded from the start of the DSN Initiative in 2007 through
August 30, 2010. 
The DSN Initiative built upon work supported by the Foundation begin-
ning in 1999. At that time, the MBDS effort was struggling with limited
resources. The unique contribution of Rockefeller Foundation funding was
the scope of the resources offered. Organizational assistance, technical tools
and capacity building are critical to assuring the success of the MBDS
regional network, and the Foundation was the pioneer funder in these areas.
Among other things, the Foundation supported an electronic platform for
reporting among the six Mekong countries (Cambodia, China (Yunnan and
Guangxi Provinces), the Lao People’s Democratic Republic, Myanmar, Thai-
land and Vietnam) to help build trust and consensus among these entities.
The development of trust through experience is just as crucial to a network’s
success as technical acuity, and the strategic areas of Foundation investment
played an integral role in developing network trust. 
New areas of the DSN Initiative included the introduction of One Health
surveillance to unite veterinary and human surveillance capacities, and global
health diplomacy to enhance transnational negotiations. The core concepts
and strategies from the Mekong region have more recently been implemented
in East and Southern Africa, with the first regional grant to an African
grantee awarded in July 2008. 
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3. Evaluation Methodology
The overall evaluation of the DSN Initiative was conducted in threeparts—in Asia by the Southeast Asian Ministers of Education Organiza-
tion (SEAMEO) team, and in Africa by the Swiss Tropical and Public Health
Institute (Swiss TPH) in partnership with the African Population and Health
Research Center (APHRC). The Global Team from the University of Wash-
ington acted as a coordinator, backstopping the regional evaluations through
the provision of access to scientific literature, the sharing of tools and techni-
cal advice, and coordination of communications. The Global Team was also
primarily responsible for the evaluation of grants that were made in more
than one region or globally. 
The evaluation was designed using the Organization for Economic Coopera-
tion and Development/Development Assistance Committee (OECD/DAC)
evaluation criteria of relevance, effectiveness, efficiency, impact and sustain-
ability.
The evaluation questions were developed by the Managing Director for 
Evaluation of the Rockefeller Foundation in collaboration with the Lead
Evaluator and in consultation with the senior leaders of the Foundation. 
A matrix of questions for the global and two regional evaluations were 
prepared sequentially during the evaluation process. The global evaluation
matrix can be found in an Annex to this report and helped steer the 
formulation of interview guides and questionnaires, coding, and analysis for
the global-level work. 
The evaluation design was greatly aided by the outcome mapping of all 
DSN Initiative grants undertaken by the DSN Initiative team at the outset of
the evaluation. Grants were mapped to all four outcome areas (networking,
capacity building, new tools and approaches, and One Health), attributing
percentages of each grant in the portfolio to each outcome area. A copy this
mapping can be found in an Annex to this report.
Two fundamental elements for the global work were developed early in the
process: a stakeholder analysis and a theory of change model. 
u Stakeholder Analysis—Given the diversity of grants and outputs in the
DSN Initiative portfolio, a theoretical mapping of stakeholders was ini-
tially developed by the Global Team and tested systematically through the
Team’s in-depth grantee interview process.
u Theory of Change—the Global Team reconstructed and reconfirmed a
theory of change model based on initial grant review with the core staff of
the Foundation responsible for the DSN Initiative. 
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u Access to Information—Consistent with a separate analysis carried out of
the DSN Initiative portfolio by Universalia Management Group3, despite
major efforts by staff at Rockefeller Foundation Headquarters and at the
Regional Office in Bangkok, many key documents describing the DSN
Initiative’s portfolio of work were not accessible through the Foundation’s
databases and proved difficult to obtain. Access to information was also
reliant on pre-existing relationships of the lead evaluator and lead regional
evaluator (SEAMEO) in gaining key informant interviews, access to rele-
vant meetings and high-level policy input. This problem was particularly
an issue for the Global Evaluation Team where many communications
needed to be done at a distance, but for whom the quality of information
mandated an “in-person” (rather than an email or telephone) mode of
information gathering. Access to such opportunities proved challenging.
u Development of questions, tools and methods—The Global Team used a
heuristic approach to the development and finalization of methods, tools and
specific questions to address the criteria areas and sub-questions of the matrix. 
u Network Analysis—The Global Team introduced and used network 
mapping in the evaluation analysis to provide a more detailed and granular
level of analysis of the disease surveillance networks in Asia and Africa. 
A regional network analysis expert from the Population Institute of Mahi-
dol University in Bangkok, was contracted to support the Mekong region
and global network analysis.
u Support of Regional Evaluations—The Global Team also undertook
extensive technical support for the regional evaluation efforts. 
u Evaluation Advisory Committee—An Evaluation Advisory Committee
(EAC) was used to ensure a well-designed and thorough evaluation. Evalu-
ation specialists reviewed the approach of the evaluation teams, provided
coaching to teams, and feedback on methods and workplans. The Terms
of Reference for the EAC is included in Annex 4.
Data Collection
The evaluation matrix sets out the specific data sources for each set of questions,
including data collected from external stakeholders, grantees, grant participants,
and Rockefeller Foundation staff through in-depth interviews, focus groups, 
and surveys. Team members observed key meetings of global stakeholders and
grantees. Data was also gathered through a desk audit of Foundation docu-
ments and a review of literature and media sources. A full discussion of meth-
ods, tools and question development is included in an Annex to this report.
The focus of the data collection of the Global Team was not only to gain
qualitative insight into the work, but to triangulate through stakeholders’
impressions of grantees and beneficiaries to confirm findings for all teams. 
3.1 
3 DSN Dashboard Draft July 20, 2010, Universalia Management Group October 2010
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4. Findings
The Global Evaluation Team identified a number of key overarching find-ings. They are described here, with additional findings below specific to
performance area.
Key Overarching Findings
[1] The evaluation team found broad support for the hypothesis that robust
trans-boundary, multi-sectoral/cross-disciplinary collaborative networks
lead to improved disease surveillance and response. The majority of sur-
vey respondents confirmed the relevance of this hypothesis. Many of
them who were from areas without a regional DSN expressed a desire to
see regional DSNs developed in their areas. Global leaders also confirm
the value of regional networks. However, the analysis of measurable indi-
cators that would quantify changes to improved surveillance and
response on the ground was outside the scope of the Global Evaluation.
The Mekong Region Evaluation provides substantive evidence of
improvements in surveillance practice and response time.
[2] The Rockefeller Foundation is seen by high-level decision makers, policy
leaders and regional and national counterparts, as a thought leader and
pioneer investor in networks for public health; sub-regional governance
in public health; innovations in tools and approaches; and global health
diplomacy. The Foundation is perceived to a lesser extent as a leader in
the more technical field of public health surveillance, which is appropri-
ate. This distinction is important in defining the Foundation’s niche and
added value. 
[3] The Rockefeller Foundation’s role and niche in disease surveillance is
widely viewed by global actors as the ability to convene actors from
many sectors and regions to introduce and discuss new and innovative
topics. The evaluation team found that stakeholders associate the Foun-
dation with inventive and progressive thinking. The global grants in the
Foundation’s DSN Initiative portfolio drew heavily on this niche, and
used the Foundation’s convening power very effectively to create global
communities of practice. 
[4] Our mapping of grant activities suggests that design and innovation flowed
from the local to global levels for certain tools and outcome areas, and from
global to local levels in areas that required systematic change and the accept-
ance of new theories and concepts.Through discussion with DSN Initiative
officers, it is apparent that the logic of the portfolio evolved rationally as
lessons learned were innovatively adapted between regions. Systematic
capture of the evolution process was not found during this evaluation. 
[5] Grantees selected were generally capable of using the Foundation’s funds
and reputation to accomplish the activities they set out to do. The port-
folio review revealed that grantees delivered outputs as contracted, in
general, with modifications to scheduling and funds disbursement 
4.1 
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varying somewhat from the original timeframes. The perception of the
quality of outputs for global grantees varied widely between stakeholders
based on the novelty of the product. For example, global health diplo-
macy was seen as relevant by stakeholders, while there remains some 
discord around the actual definition in the field.
[6] The Global Evaluation Team looked closely at the outputgoutcomeg
impact pathway to determine the extent to which conclusive outcome
and impact statements could be made. Our findings, based on the views
of both global stakeholders and grantees, is that the work of the DSN
Initiative is just now maturing, and evidence of practice changes and
attitudes is now evident. Change and innovation is taking place within
each outcome area to a high extent, but needs additional time and funds
to come fully to fruition.
[7] Findings based on historical program areas, network mapping, and
recent views of the Foundation, all support the Foundation’s niche and
comparative advantage in developing meaningful networks. The global
network map clearly illustrates network ties generated by Foundation
funds. In addition to technical network ties, scholars and practitioners
see the high value of networks as it relates to creating a base for regional
stabilization, cooperative efforts, and peace.
[8] Rockefeller Foundation strategy, information systems and monitoring
and evaluation practice were found to be underdeveloped at the time the
evaluation was undertaken. The evaluation was hampered by the lack of
systems support for metrics of population health measurement which are
critical evidence in prioritizing surveillance and response activities within
and across countries. There was minimal evidence of an exit strategy for
longstanding investments in Southeast Asia prior to the Foundation’s
decision to close the portfolio, creating a risk to longevity of assets devel-
oped through DSN Initiative funding.
[9] The evaluation team noted a lack of emphasis on documentation in the
peer-reviewed and non-peer-reviewed literature of the work of the Founda-
tion for most DSN Initiative grants and outcome areas. It is crucial that
the Foundation and its grantees record the social and scientific advances
associated with Foundation funding. This is essential to enhance the visi-
bility of important contributions in public health practice made by the
Foundation’s investments.
[10]Through ongoing interaction with the Foundation, the evaluators found
that the importance of evaluation has been recognized within the Founda-
tion, bringing with it several strategies to improve the ability to monitor
grantees, share learning, and access data and records within the Founda-
tion. As the Foundation demonstrates the value of evaluation in creating
better portfolios and meaningful change, it will contribute to the field of
philanthropy by using monitoring, evaluation and learning for quality
improvement, and by modeling accountability to stakeholders and users.
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Situation Analysis and Rationale of Portfolio
u The regions that received the majority of the grants are known to be
hotbeds for emerging infectious diseases (Figure 1). The Mekong region is
highly influenced by globalization because of its central location between
the two most populous and fast-developing countries in Asia, India and
China. Emerging infectious diseases such as severe acute respiratory syn-
drome (SARS) and highly pathogenic avian influenza (HPAI) had been
identified when grantmaking began, making this a logical location to
improve disease surveillance efforts. The Mekong region investments were
made initially to an existing network that had the political support of the
participating countries and the WHO’s Western Pacific Regional Organi-
zation’s (WPRO) regional office, but was struggling with a lack of struc-
ture and resources. This grouping of countries was primarily organized
around the practice of keeping “health” as a conflict free space to enhance
relationships in post conflict areas such as the Mekong region. East African
investment created a health related network based in an economic political
grouping. Control of diseases in these regions is important to the margin-
alized populations living in the border areas and to the security and eco-
nomic development of the regions and the world. 
u The Rockefeller Foundation has supported MBDS since 1999, and there
is strong evidence that the network has demonstrated effectiveness in
reporting and containing outbreaks such as dengue, SARS and influenza.
Trust and collaboration developed to a very high level over the years have
decreased the tendencies to cover up disease cases and have increased the
capacity to respond. 
u Africa is a priority region because the data maps for diseases such as
influenza are practically blank. During a key informant interview, a global
expert stated that currently, data about influenza only comes from 100 lab-
oratories in two countries, demonstrating the vast need for Information and
Communication Technologies (ICT) and capacity building in the region.
u The two continents chosen for the DSN Initiative are linked together
through common characteristics that made them candidates for DSN Ini-
tiative grants. Specifically, evidence supports the Foundation’s rationale for
funding both regions, which have fragmented surveillance systems and a
high level of human-animal interaction through wildlife and agriculture.
Thus, the DSN Initiative strategy shares similar objectives in both regions: 
u To increase the human workforce capacity for disease surveillance to predict
and respond to emerging diseases
u To improve collaboration between human and animal health practitioners
through a One Health model
u To increase the network ties between countries to promote further capacity
building within the regions.
Amazon Congo 
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Additionally, history shows that diseases may have a larger impact in these
two regions. During the 1918 influenza epidemic, the death rates were 10
times higher in India and South Africa than in the United States or the
United Kingdom.
Sequencing of DSN Initiative work
The Global Evaluation Team constructed a timeline that illustrates the 
development of the DSN Initiative and its components over time.
u The grantmaking of the Initiative started in 2007 in the Mekong region,
assessing needs there, strengthening the existing networks and building
upon earlier work in ICT and capacity building that the Foundation had
funded previously. Grants were made to formalize the MBDS network,
which was used as a model for later grants in Africa, and as an example
during the convening of regional DSNs at Bellagio. 
Figure 1. Hot Spots for Emerging Disease Threats. Kate Jones et al (2008): Global trends in emerging
infectious diseases: Nature, Vol 451.21.
u The One Health approach was prioritized first globally and in Africa. Two
global grants and one African grant in 2007, targeted the One Health
approach, while grants targeting One Health in the Mekong Basin sub-
region did not emerge until 2008. 
u In 2008, the main focus for the Mekong Basin sub-region was on capacity
building and One Health. Many African grants were initiated the same
year and were largely mixed-focus grants with two One Health grants and
one on capacity building. The global focus on One Health was sustained,
and additional efforts were made on global health diplomacy through 
Bellagio meetings.
u In 2009, most grants targeted the African sub-region or a global prospec-
tive. African grants targeted multiple outcome areas and ICT tools. Glob-
ally, a grant was funded to implement executive education in global health
diplomacy, and a subsequent grant was funded to monitor health diplo-
macy. Evaluations of the Foundation’s DSN Initiative globally and region-
ally were also funded. 
This sequence of grants is conceptually robust. However, the coherence of
the portfolio suffered due to frequent changes to the DSN Initiative staff
over the course of its lifetime.
Program Logic and Evolution of Portfolio
u The programmatic logic flows from the local to global level for networks
and ICT, developing tools and network governance structures that can be
replicated elsewhere and on a grander scale, whereas the grants demon-
strate a flow from the global to the local level for One Health and health
diplomacy. These global-based grants help set the theoretical frameworks
of these emerging fields and seek to gain stakeholder buy-in prior to
implementing practice changes. Both of these fields require large changes
at the systems level. Programmatically the outcome areas intertwine logi-
cally to a great extent, as tools contribute to capacity, capacity contributes
to new fields of practice, and collaboration interrelates all the other out-
come areas.
u The shifts in focus over time, in part due to the changes of DSN Initiative
staff, often align with changing global political and public health climates
that were shaped by events such as SARS, H1N1 and Avian influenza out-
breaks, the International Health Regulations established by the World
Health Organization (WHO), and changes in lab sample sharing practices.
These events increased the focus on human/animal health, providing a
rationale for developing the One Health perspective, and also spotlighted
the growing need for health diplomacy. While this evolving focus compli-
cates the assessment of DSN Initiative grants as a portfolio, it does
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demonstrate that the initiative was responsive to disease surveillance chal-
lenges faced by the global health community. Key informant interviews
with multiple stakeholders validated the One Health perspective and the
need for more health diplomacy.
Rationale Behind Regional Investments
u According to numerous sources, the DSN Initiative is an exploration of
whether networking at a regional level inherently builds country capacity.
Experts and stakeholders broadly support the hypothesis, and the evalua-
tion found evidence to support it on regional levels. Stakeholders believe
networks can be an entry point for strengthening national health systems
toward universal health coverage, acting as a catalyst to stimulate new
research, and providing a resiliency mechanism in regions where they are
active. The regional network structure promotes sharing knowledge,
resources and best practices that will improve a country’s efficiency in
adopting effective surveillance and response systems. Network structures
are broadly seen by our data sources as a way of distributing capacity and
assuring timely access to technical capacity in resource-poor settings. The
ongoing MOU mechanism in the MBDS indicates the governments are in
agreement with this view. 
u Some experts take the view that a country or disease-specific approach may
be more relevant than a regional approach. However in terms of “Smart
Globalization” the increasing transnational nature of pandemics suggests
this is not an “either/or” situation, but more likely a situation where the
word “both” better applies—which is reflected in the MBDS grants to
each member country. Concern was also stated about focusing on emerg-
ing diseases rather than diseases that are easily treated with known and
available remedies. However, this latter concern contradicts the actual pri-
ority disease focus of the networks, which emphasizes known diseases with
high transmission potential, such as cholera. 
u Transnational investment is innovative, as many other organizations fund
at the national level. Stakeholders concluded that both networks and indi-
vidual country investments are relevant to disease surveillance and ongoing
healthy tensions should exist between them (e.g. when a particular country
is lacking infrastructure for disease surveillance, an individual country
investment may need to occur first in order for a network to be effective).
To achieve a balance, the niche of different networks should be investi-
gated, and appropriate robust evaluation activities that look at population
health metrics should be implemented. 
Relevance
Concept/Rationale 
Findings

u Through the DSN Initiative, the Foundation articulated the importance 
of a multidisciplinary and multifaceted approach to preventing the spread
of disease in a world of rapid and constant global interaction. The threat
of emerging infectious diseases was addressed using a variety of innovative
methods and promoted new conceptual approaches to global health, many
of which have been adopted by other funders and organizations in the
global health landscape.
u The intersectoral work in One Health has a robust theoretical basis in the
zoonotic origin of human pathogens and the changing nature of animal/
human exposure and risk. The practice of strengthening linkages between
sectors and intervening in the disease emergence pathway is in the early
stages of development. 
u Global health diplomacy has an ambitious agenda to set out a new field
linking diplomacy and health. One challenge, especially among developing
countries, is prioritizing issues amidst political and economic pressures.
Supporting countries so they develop the capacity to address local and
solvable issues, rather than focusing solely on emerging diseases is highly
relevant, and is highlighted by situations such as sample sharing for
influenza vaccine (i.e. Indonesia 2007) between developing countries and
global health organizations. 
u Rockefeller Foundation documents accurately lay out a complex situation
involving unpredictable disease emergence, a need for collaboration within
historically unstable regions, increasing globalization that negatively impacts
EVALUAT ION  QUEST IONS  
To what extent is the DSN Initiative based on robust conceptual think-
ing in the fields of health and development (transdisciplinary concepts,
ecohealth, One Health, etc.)?
Is there a clearly articulated situation analysis that provides the ration-
ale for the DSN Initiative and demonstrates its relevance?
To what extent does the DSN Initiative respond to global and regional
issues and trends?
To what extent are global and regional issues and trends understood to
be driven by network phenomena?
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marginalized populations, and an overall lack of capacity to protect the
world’s peoples from widespread disease outbreaks. The rationale behind
the initiative provides strong justification for the Foundation’s ongoing
work in the field of disease surveillance networks and related projects.
u The presence of the Foundation’s regional offices in Asia and Africa, along
with capable staff to provide guidance and oversight, have ensured that the
DSN Initiative is highly responsive to emerging situations and opportuni-
ties in Asia and Africa.
u Disease surveillance is adapted to the political and institutional landscape
of a country or region and at times includes non-traditional members of a
disease surveillance system, with this inclusiveness extending to the local
level as documented at cross-border sites. 
u Creating a global “safety net” is the key thrust of the International Health
Regulations adopted by the World Health Assembly in 2005, and in force in
2007. While the SEAMEO evaluation documents a strong awareness of and
focus on International Health Regulations (IHR) implementation through
MBDS, key informant interviews at the regional level were less sanguine
about the contribution of the network to the effort. At the WHO’s South-
east Asian Regional Organization, the MBDS was seen almost as a competi-
tor to the Asia Pacific Strategy on Emerging Diseases (APSED) process, and
a desire was expressed for all resources to flow through the latter. At WPRO,
there is more familiarity with MBDS, but less active collaboration lately
between the Regional Office and MBDS. As global health diplomacy as a
field matures and becomes more “grounded,” a clearer analysis and remedy
for tensions between organizations at the regional level may emerge. 
u Existing regional agreements in place are well summarized in the
SEAMEO evaluation report, and it is clear that the network model is
being adopted to address numerous global health challenges by many
organizations and associations. Disease transmission in particular is
increasingly recognized as regional and global, spreading through natural
networks established through increased mobility. 
Discussion
The conceptual thinking behind the DSN Initiative portfolio is considered
robust consistently across all intended outcome areas and outputs by multiple
sources of data. The concepts applied range from the very practical (i.e., the per-
formance of disease surveillance and response) to the very theoretical (i.e., the
development of health diplomacy as a discipline). The thought leaders involved
in the Foundation’s DSN Initiative are regarded as preeminent thought leaders
and authors in the field so triangulating the value of this is challenging. The
breadth of thinking has allowed a few key topics to come to the forefront of
surveillance: the importance of nontraditional surveillance, and “trust-based”
interactions in disease reporting and response—a hallmark of the MBDS. 
Situation analyses were clearly articulated for the networking, information, com-
munications and technology and capacity building components of the portfolio.
The speed of the transmission of diseases and the acknowledgment of zoonotic
sources of disease were well articulated and align with the portfolio goals. In
capacity building, while the inadequacies of systems are well known, the specifi-
cation of training, placement, career paths and future in-service training needs
for One Health and public health workforces lacked explicit targets aligned with
justified workforce needs in the participating ministries, provincial offices or
other sites. There is mention of a formal process to review these human resource
needs in Foundation documents. However, follow-up discussions with project
team members suggest these efforts (a joint learning initiative and mapping of
health personnel) were not accomplished. For global health diplomacy, the spec-
ification of situation analyses is largely case based, and thus could be considered
anecdotal, as often occurs in the emergence of a new field of study. 
One question around the network rationale is whether disease processes of
transmission are driven by networks? The answer is unequivocally “yes,” with
social networks, travel networks and trade networks leading the list. The focus
on infectious disease in DSN is clearly “using a network to address a network
phenomenon.” A second question concerns the extent to which innovation,
policy advances and overall success in improving human health are driven
through the creation of networks among institutions and individuals, and that
is also widely understood to be true. This is reflected not only in the DSN
networks and their relationship to other networks as outlined in the Organiza-
tional Network Mapping done in this evaluation, but in the proliferation of
networks in the two target regions and globally as mirrored in those results. 
Logic
Findings 
u The logic of the portfolio is based solidly on evidence and expert opinion.
Networks, capacity building, One Health and global health diplomacy are
supported to a great extent as validated through various interviews with
grantees, Foundation managers, and stakeholders, as well as Foundation
background documents. The logic for ICT tools development was not
emphasized in our data sources. This may imply that is not as well ration-
alized within the overall portfolio and its objectives, or that the logic of
ICT tools is assumed and did not warrant explicit statements. 
4.2.2 
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EVALUAT ION  QUEST ION  
To what extent is the logic of the DSN Initiative supported by evidence
or expert opinion?
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4.2.3 
u According to the Foundation’s background documents, the landscaping for
the DSN Initiative encompasses more than 50 organizations and individu-
als of diverse experience, expertise and background, demonstrating a com-
prehensive vetting of expert opinion. 
u Stakeholders suggest that there should be a mix of activities for all the out-
come areas, and that the different work areas should be linked for more
synergy among grantees. 
User Needs
Findings
To answer this question, the Global Team developed a stakeholder mapping
for the global level analysis.The relevance for civil society regionally is
addressed in the more granular regional evaluations. 
u In all outcome areas, the global evaluation data confirmed the overall 
relevance of Foundation investments to user needs. 
u A major strength of the MBDS is that the meetings have been held in dif-
ferent countries each time and in locations outside of the capital cities.
This allows people to better understand the local culture and the situations
on the front lines of disease surveillance to build a response that is most
relevant to user needs.
u The need for global health diplomacy training was highlighted by events
on the regional level, but was conceptualized by global teams that devel-
oped curricula that integrated health and foreign policy concepts. Many of
the ICT tools developed are based on regional needs and are being tested
within regions. 
u The key disease surveillance stakeholders had a strong voice in the prob-
lem formulation of the DSN Initiative. The initiative was developed in the
Asia region in close proximity to stakeholders. Meetings that brought all
the players together were held to set their own priorities and ways of work-
ing together. Input from national programs was also incorporated from the
very beginning. Early discussions around initial investments in the Mekong
region (1999-2000) involved not only the prospective members, but also
their regional and global counterparts in WHO.
EVALUAT ION  QUEST IONS  
To what extent is the DSN Initiative relevant to the needs of stakeholders
and users, including the public, in Asia and Africa?
Were key stakeholders involved in the problem formulation?
Discussion
The MBDS network served to highlight needs in the region and promoted
regional collaboration through joint planning and implementation of pre-
paredness. The creation of new electronic tools for surveillance answered a
long-standing concern with outdated, paper-based reporting in the Mekong
region. ProMED as an informal reporting mechanism was seen to facilitate
transparency on issues such as cholera, which countries are reluctant to report.
Health diplomacy is at an early stage of development, and has thus far
focused on the interface between developing countries and global agendas.
An example was cited by a key informant in Bangladesh where 4 million dol-
lars has been spent on making H1N1 vaccines available without addressing
more pressing health needs of the population. A country-by-country
approach could be useful in assuring that trainees in this new discipline are
well deployed in their home countries. The more regional and global net-
working approach currently in place is a logical approach at this stage. An
additional need articulated was for South/South diplomatic skills to enhance
cooperation. If health diplomacy can help solve South/South issues, donors
may be able to move past individual country investments and support other
needs. Thus, using the network to incubate the discipline and insure its even-
tual success will have resonance at the country level. 
Role/Niche/Comparative Advantage
Findings

u This work corresponds to the historical niche of the Foundation to a high
extent. The Rockefeller Foundation has a rich history of building public
health infrastructure in areas where it is most lacking. It has historically
convened essential institutional actors to establish networks and collabora-
tions to tackle large problems and it has a reputation for promoting inno-
vative approaches in health and working across silos.
4.2.4
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EVALUAT ION  QUEST IONS  
To what extent is this area of work a historical niche of the Foundation?
If it is not, is there a clear rationale to explain why the Foundation chose
this Initiative area?
To what extent does the Foundation have a comparative advantage in
the disease surveillance field and key related fields?
u Legacy programs in the Foundation include components of animal 
health, network construction, and capacity building in public health.
These elements of the Foundation’s niche and advantage played a major
role in the success of DSN Initiative efforts. 
u The Rockefeller Foundation has a comparative advantage in organizing
networks for disease surveillance. The Foundation has the flexibility to
respond to local needs because it is independent of larger political struc-
tures that constrain other health actors. 
u The Foundation can convene and orchestrate the necessary players to
instigate conversations around topics of great importance. Using the Bella-
gio Centre the Foundation promotes innovative ideas and encourages peo-
ple to “think big.” The Foundation has a legacy of creating new fields of
knowledge. Thus, the Foundation is seen as a leader and initiator of key
importance in the field. 
u Novel approaches to disease surveillance may gain more traction when
backed by the Foundation because of the reputation and trust it has
worldwide. As one grantee stated, “The fact that we’re able to say we’re
supported by Rockefeller Foundation opens a number of additional doors
because that is a name that people respond to with very great trust.”
Value Added, Alignment and Leadership
Findings
u Many key informants supported the value of the Foundation’s efforts in
the networks and global health diplomacy pieces of the DSN Initiative,
and see the Foundation’s work as building the infrastructure that societies
need to fulfill their public health obligations. 
u On the questions of whether some results of the DSN Initiative might
have been achieved without Foundation funding due to the dynamism of
4.2.5 
EVALUAT ION  QUEST IONS  
To what extent did/does the Foundation add value to the disease surveil-
lance field and the work of stakeholders? In what ways?
How would disease surveillance have progressed without Foundation
funding?
To what extent is the Rockefeller Foundation seen as a leader in the field
of disease surveillance?
To what extent is the DSN Initiative aligned to the mission, strategy and
intended results of the work of the Foundation?
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the disease surveillance field, evidence from both the Global and Mekong
region evaluation reports suggests that timely Foundation funding was
necessary for efforts to progress effectively, and that without these funds
grantees’ work might have foundered.
u Stakeholders had differing views of the Foundation’s mission and strategy,
and as a result their view of alignment of the DSN Initiative were not always
the same. During the focus group held with high level policy makers partici-
pants interpreted the meaning of the Foundation’s strategy differently. 
u However, based on internal interviews with DSN Initiative staff within the
Foundation, we found that there was good alignment between the intended
results of the Foundation and the work of the DSN Initiative. The innova-
tive and collaborative approach to minimizing the impact of disease out-
breaks aligns well with the strategy of the organization to improve the 
lives of poor and vulnerable people through increased resiliency and more 
equitable growth. The aim of decreasing the impact of disease outbreaks
because they disproportionately affect poor and vulnerable populations
strongly aligns with the Foundation’s mission. Stakeholders emphasized the
importance of the Foundation knowing and defining their strategy direc-
tion internally in order to be effective in their investments.
u The role of the Foundation as an early and innovative leader and funder in
DSN is clear in emphasis on integrated disease surveillance; use of net-
works in public health; new models of public health governance at the
sub-regional level; and One Health and global health diplomacy. In One
Health, the Foundation predated many in emphasizing this interface in
grantmaking through DSN.
Effectiveness
 Planning and Strategy
4.3 
4.3.1 
EVALUAT ION  QUEST IONS  
Was the DSN Initiative adequately planned?
What was the internal situation in the Foundation when the DSN Initiative
began and was there strength in this positioning to launch the Initiative?
Did the DSN Initiative build on existing networks and collaborations? How?
Did the Initiative identify places for early wins to leverage momentum for
the future? If so, how?
Identify the evolution of the strategy over time. What factors have 
contributed to its evolution?
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Findings
u The planning and strategy for the DSN Initiative were adequate to
achieve the outcomes of the Initiative. The DSN Initiative team managed
to the proposal approved by the Board which clearly outlines proposed
activities that would be undertaken during the life of the Initiative, nam-
ing partners and projects that would contribute to the resolution of the
problems identified in the situation analysis. The subsequent results and
outcome mapping of grants helped to focus and evolve the work over
time and allowed the introduction of new collaborations such as global
health diplomacy.
u The proposal briefly describes anticipated impacts, potential risks, assess-
ment criteria and a budget. The DSN Initiative was positioned to build on
existing collaborations with grantees in the Mekong Basin and other part-
ners globally to address inadequate capacity for coordinated response to
disease outbreaks within the region and globally.
u A number of situational factors helped make this a timely initiative: the
agreement of countries within the regions to abide by the IHR (2005),
increased awareness that new diseases emerged at the human-animal 
interface, and a trend toward open and informal information sharing,
amid the emergence of new diseases with pandemic potential such as
HPAI and H1N1.
u Many of the grantees funded through the Initiative had established rela-
tionships with one another prior to the launch of the DSN Initiative, 
especially in relation to ICT, global health diplomacy and One Health.
Specifically, the WHO and the Graduate Institute collaborated on the
development of global health diplomacy. ProMED was becoming well
known in the regions, and Tufts and the University of Minnesota worked
in partnership prior to and following their DSN grants.
u Many of the grants at the global level aimed to convene experts in health,
diplomacy, disease surveillance, food safety, agriculture, and networks.
These meetings pooled knowledge and developed calls to action, stating
commitments to work toward the resolution of global health problems. 
It is important to note that convening at Bellagio has been an excellent
strategy for consolidating planning and strategy. From the eHealth summit
series, to the disease surveillance networks meeting to global health diplo-
macy, the use of the Bellagio facility has been key to the success of DSN. 
u Changes to plans occurred minimally on the individual grantee level.
Overall, the major changes of the Initiative consist of including work not
proposed in the original documentation, such as global health diplomacy,
or certain grants in the Africa regions (traffic risks). 
u The profile of grants looks slightly different between Asia and Africa because
of the length of time that the DSN Initiative was active within each region
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(longer in Asia) and the unique opportunities and partnerships that arose
within each region. The adaptation to the environment was assisted by the
strategic selection of grantees that had established relationships in the region.
Grantees were often involved in or able to access global communities of
practice and used the Foundation’s convening power to catalyze conversation
and commitment to address issues such as food security, global health diplo-
macy and best practices in regional disease surveillance networking.
Outputs
A summary of outputs of the DSN Initiative by outcome areas is shown in
Table 1 (see following pages). 
Findings
u The extent to which individual researchers were identified was rated fair,
except in the global health diplomacy outcome area in which more efforts
were made to publish research. Global health diplomacy grantees identi-
fied the need to establish a literature base for the emerging field. One
Health also highlighted the work of individual researchers through the
Tufts grant, and other grants on the regional level.
u The quality of some meetings that brought together grantees (Annecy-
CHORDS) was not ranked as highly by some respondents. Participants
believed that some of the presenters and discussion leaders had inadequate
expertise which decreased the relevance of the meeting. In addition, partic-
ipation in the second disease surveillance networks meeting and its gover-
nance was controversial because of predefined roles created by those who
convened the meetings. This has recently been acknowledged and over-
come (see Summary remarks). 
EVALUAT ION  QUEST IONS  
Describe the planned and actual products and services delivered by 
the Initiative.
To what extent are outputs perceived to be of high quality?
To what extent has the Initiative developed high quality instruments 
that have been tested to assist in best practice?
Have individual researchers been identified and included to enhance 
their capacity in research?
4.3.2 
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u Definitions of One Health and global health diplomacy are not uniformly
understood among stakeholders. As these concepts continue to become
integrated into the policy agenda, efforts should be made to establish a
common understanding with key stakeholders.
u ProMED has continued to grow its user base, but many stakeholders ver-
ify ProMED reports using more formal sources. ProMED appears to have
been positioned as the sole “feedback” mechanism for MBDS, which may
have prevented the more thoughtful development of appropriate regional
dissemination by MBDS members. 
u In general, grantees sought to use best practices in the development of
their products, and many consulted with a number of experts to create
quality outputs.
u Though some of the work is considered low profile, high level decision
makers felt that the Foundation adds value by having a long term view of
investments.
Summary of Outputs for Grants in the Global Evaluation Grant Basket
Outcome 
Area
Proposed 
Outputs
Planned Outputs From
Grant Documents
Actual 
Outputs*
Networks A global network 
of disease surveillance
networks that share 
experiences and 
lessons learned, 
and forges new 
relationships. 
Convene experts to 
share knowledge and
ideas to improve cross-
border collaboration and
early detection of 
disease outbreaks.
A forum of represen-
tatives of disease
surveillance networks
from around the globe
was held to share best
practices and develop a
framework for future
collaboration.
Establish a global
community of infectious
disease surveillance
practitioners with a focus
on sharing best practices
in governance, training
and the deployment of
appropriate technologies.
Connecting Health
Organizations for
Regional Disease
Surveillance (CHORDS)
was launched to
implement the Bellagio
“Call to Action.”
cont.
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Outcome 
Area
Proposed 
Outputs
Planned Outputs From 
Grant Documents
Actual 
Outputs*
ICT Demonstration or pilot
projects that illustrate
how ICT can be used in 
disease surveillance and
response.
Operate the ProMED
listserv, improve the
sensitivity of disease
reports, overcome
language barriers
through the adaptation
of GPHIN, and develop
the ProMED-MBDS
website.
PRO/MBDS continues to
operate a listserv and
website, and the network
of subscribers has grown.
Regarding issues of
language barriers, there
has been an increase in
coverage of Chinese or
Thai language media.
Chinese and Thai
language websites were
also developed.
Layered training and 
institution-building to 
strengthen the ability to
apply information
technologies to public 
health practice today.
Through CHORDS build
effective information
structures and utilization
of ICTs to improve
connectivity,
communication and
sharing especially for
countries with limited
resources.
Wiki and other web-
based communication
and information
exchange structures are
in use for CHORDS
participants.
n Findings
Summary of Outputs for Grants in the Global Evaluation Grant Basket
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Outcome 
Area
Proposed 
Outputs
Planned Outputs From 
Grant Documents
Actual 
Outputs*
One 
Health
Bridging animal-human
health and establishing
early warning systems
through community-
based participatory 
surveillance, training 
and workshops.
Assemble a group of
physicians, veterinarians,
scientists, and other
health professionals who
are trained in disease
outbreak reporting and
provide a forum to
disseminate information
and foster partnerships.
Develop a zoonotic
disease risk manage-
ment capacity assess-
ment tool, a compre-
hensive curriculum on
zoonotic diseases, 
and conduct training
workshops for human,
animal and agricultural
sectors.
A workshop was held to
explore zoonotic disease
risk and possible
mitigating methods.
A capacity assessment
tool was developed to
evaluate national
preparedness in dealing
with zoonotic diseases
outbreaks.
Explore opportunities to
support partners in the
development of new
veterinary-public health
educational models.
Conduct an assessment to
determine the needs of
veterinarians and the
potential benefit of
advanced education in
veterinary public health.
An assessment of the
veterinary public health
education systems in
Indonesia and Thailand
was conducted to
identify needs and gaps.
Identify and support
alternative business
models to help secure
poor people’s livelihoods
and allow them to
participate in food supply
value chains.
Formulate a strategy to
develop “one world, one
health” leadership
capable of managing
complex dilemmas
affecting the global food
system.
The Bellagio “One
Health” leadership model
was shared.
“The Ranikhet
Declaration” was created
to affirm the work done
at Bellagio related to
food security and commit
partners to further
activities. 
A framework was
developed through the
work on food security
that is scalable to a
variety of contexts.
Summary of Outputs for Grants in the Global Evaluation Grant Basket
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Outcome 
Area
Proposed 
Outputs
Planned Outputs From 
Grant Documents
Actual 
Outputs*
Capacity 
Building 
Not specified 
in Initiative
Proposal
Identify core competencies and
approaches to capacity building;
share guidelines and protocols
for cross-border surveillance and
response.
Conduct trainings specifically for
MBDS members and ProMED
personnel. 
Build laboratory capacity by
identifying the needs for
technical support and equip-
ment to achieve rapid
diagnostics and safe handling of
pathogenic materials and
operations in the laboratories.
Develop trainings for field
epidemiology personnel and
apply distance learning to
building capacity where needed.
An outline of capacity
building competency
development and 
leadership education
approaches based on 
17 different learning styles
was drafted. A competency
model was created, and
approaches for developing
and nurturing these com-
petencies were defined.
Various training courses
were held. 
The Bellagio “Call for
Action” was endorsed,
pledging to continue
regional and global
collaboration and to
promote disease surveillance
capacity.
Capacity building was
promoted through
agreements with MBDS and
MECIDS.
Global 
Health 
Diplomacy
Not specified 
in Initiative
Proposal
Define an academic discipline at
the nexus of global health and
foreign affairs.
Hold a series of meetings 
at Bellagio on global 
health diplomacy
Develop a global health
diplomacy network. 
Develop the Health Diplomacy
Monitor, a monthly publication
covering negotiations related to
global health.
Develop various training and
capacity building activities in
health diplomacy and foreign
policy. For example, develop a
training manual for health
diplomacy and web-based
modules for executive education
and building negotiation skills.
A training manual, a
textbook, and two other
publications on global
health diplomacy were
published. 
Three meetings on global
health diplomacy were held
at Bellagio to discuss
training, research, and
information sharing.
The Health Diplomacy
Monitor, which shares
information and updates
about global health
diplomacy through
publications and a website,
was developed.
Ten courses were conducted
over a four-year period, and
about 300 people were
trained.
Summary of Outputs for Grants in the Global Evaluation Grant BasketTable I: 
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Findings
u Of the three original outcome areas identified in the DSN Initiative pro-
posal, there have been great strides in each area. The One Health concept
has gained traction with key stakeholders and is widely known by local,
regional and global experts and practitioners. It has also received funding
from other major donors to prevent diseases from emerging at the human-
animal interface. 
u MBDS can and has served as a model for other regional DSNs because it
has built trust and improved communication between countries through
DSN activities. Tools have been developed and gradually integrated into
the repertoire of regional practitioners.
u The majority of outputs contribute directly to the outcome areas of the
Initiative. Global health diplomacy was added to the three original out-
come areas in order to strengthen the ability of developing countries to
interact with other counties and agenda setting global health intergovern-
mental organizations (IGOs). 
u Collaborations are taking place between sectors: diplomacy and health and
also animal and human health. There is also collaboration between coun-
tries during joint outbreak investigations and between regions through
CHORDS. Stakeholders have a wider view of the uses of regional net-
works and would support the development of such networks in regions
where DSNs are not currently in place. Grantees report increased demand
for their services and products. 
u Many stakeholders surveyed knew of persons who participated in the Field
Epidemiology Training Program and other trainings that they felt were 
relevant and useful. Assuming these trainees continue to practice in their
area, this is a direct increase in human resources for disease surveillance.
u The number of functional cross-border sites that share information
between countries has increased, and there are concrete examples of how
these border sites identified and responded to disease outbreaks in the
Mekong evaluation report. This is key to successful response to disease
outbreaks in border areas (see Mekong Region Evaluation Report). 
u Networking allows countries to use one another’s strengths, decreasing the
need to improve in every capacity and assisting in an efficient use of
resources (see Mekong Region Evaluation Report).
u The evaluation found that while regional offices of WHO may be skepti-
cal of sub-regional networks, key personnel in these networks have served
in global and regional disease surveillance scientific advisory teams and as
experts. Reporting directly from a sub-regional network to the WHO
would not be expected to occur, however under the IHR framework any
member country which is aware of a potential Public Health Emergency of
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International Concern (PHEIC) in any other member country is charged
to report it. Thus, the peer pressure within such informal networks to pro-
mote transparency among members is increasingly seen as important at the
global level of WHO and other IGOs. In addition, anecdotally there is
evidence that reporting through ProMED has involved investigations with
WHO. Stakeholders have recognized that the IHR (2005) have provided
incentives for improved disease surveillance at the regional level, and
regional networks can help countries meet their reporting obligations.
u The DSN Initiative involved diverse partners from many sectors, often
under the umbrella of single grants, promoting communication and coop-
eration across disciplinary, political and regional boundaries. 
u A major network exchange outside of DSN funded activities is the USAID
Emerging Pandemic Threats program. This program funds a number of
former DSN grantees in work related to the One Health projects they 
performed for the Foundation. The grantees from the DSN portfolio are
now collaborating on these new projects.
Discussion
The outcomes of the long-standing work in the Mekong region are more 
easily identified than in the Africa region and globally where the Founda-
tion’s work is younger. Many of the global grants have had insufficient time
to become fully established and report on solid outcomes, however emerging
evidence of influence and change is strong. Some DSN Initiative influence is
difficult to measure, such as the conversations ignited through collaborations
that continue “off-record,” but they surely do occur according to respon-
dents. The DSN Initiative has helped to develop a new lexicon in disease 
surveillance and global health through innovative ideas, however, because
there are many players in this field it may not be possible to attribute results
solely to the Rockefeller Foundation. 
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Outcomes: Organizational Network Analysis
The diverse, fragmented, and siloed set of actors participating in disease sur-
veillance 10 years ago has continued to evolve and organize under the influ-
ence of several drivers. The WHO has driven much organization through its
Global Outreach Alert and Response Network (GOARN); the US Centres
for Disease Control (CDC) has developed regional surveillance centers across
the globe via the Global Disease Detection program; and the Canadian gov-
ernment in concert with the WHO has begun to organize laboratorians in
the Global Laboratories Directory and Network (GLaDNet) laboratory sur-
veillance directory. Furthermore, organizations such as the UN’s Food and
Agriculture Organization (FAO) and Organisation Internationale d’ Epizoo-
tique (OIE) have begun to have joint meetings to improve sharing of infor-
mation across disciplines, while the International Health Regulations have
given countries a mandate to begin working together on a common frame-
work for cross-border health. 
4.3.3.1 
Figure 2. Global footprint of the DSN represented by major institutions impacted by the global grant basket (red), and
additional countries from original CHORDS meetings (blue). This map excludes the many additional countries influenced
by multinational organizations and other meetings convened by the Foundation.
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The DSN has had a clear overlap and influence on the continuing develop-
ment of these efforts, as efforts such as ProMED/MBDS provide additional
data to the larger surveillance infrastructure, while MBDS itself is cited as a
possible model for sub-regional networks and multi-country partnerships.
In addition to these examples, several DSN global grantees cited Rocke-
feller Foundation funds as helping to launch pilot projects and attract addi-
tional funds from other donors. Finally, through development of the
CHORDS network, the Foundation has established a platform for contin-
uing development and support of network exchanges as long term benefici-
aries of the initial investment. A concrete example of a network exchange
facilitated, but not directly funded, by Foundation activities is cited in the
interim report from ISID (2007 PAN 206), which was able to capitalize on
regional meetings to spread the use and adoption of ProMED/MBDS to
518 subscribers. 
u Out of an estimated 111 organizations, groups or jurisdictions funded
(13) or influenced by the DSN global grants (98), approximately 80 per-
cent are not currently represented in the 536 organizations counted among
the 23 GOARN networks identified as having organizational ties. This
finding implies that the DSN was highly effective at incorporating new
collaborative partners into disease surveillance.
u Among the DSN global grants whose proposals were available for review,
103 network relationships were originally proposed. Of two DSN grants
whose interim reports were sampled, organizational ties from interim
reports (42) outnumbered those from the initial proposals (13), represent-
ing the formation of new concrete interactions.
u The DSN connected several organizations that were not represented
among the GOARN network sample to existing networks. Many countries
that had minimal network representation benefitted from additional orga-
nizational ties from the DSN. 
u A small number of DSN grantees acted as hubs in the larger network, 
connecting dozens of other organizations to the larger disease surveillance
community, and forming additional connections between organizations
and countries already represented. Examples of these hubs seen in the net-
work graph include the International Society for Infectious Diseases, the
WHO, and the Wildlife Conservation Society.
u In this case, we were able to provide a snapshot of the global network and
show how DSN-funded grants impacted relationships in the network,
with deeper and more extensive ties between organizations and countries.
Systematic data collection in future initiatives could help reveal the evolu-
tion of these networks over time in response to funding. 
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u Among two grants compared between proposal and interim reports, far
more concrete organizational ties had been formed than those initially pro-
posed. This may be evidence of the catalytic effect of the grants; it also
speaks to the importance of capturing in grantee reports the actual organi-
zational relationships formed. The countries impacted directly by DSN
funds were evenly spread across Africa, Asia, Europe, and North/Central
America, with some representation in Oceania and South America. These
countries represent a population of approximately 2.6 billion people. Many
countries in the preexisting network are represented by at least two organi-
zational links. Most countries (105) show only one link, and none of these
were impacted by Foundation funds. However, these 105 countries, includ-
ing many island nations, have a combined population of under 1 billion.
This implies that the DSN impacted more populous countries with greater
access to the disease surveillance infrastructure, and hence may have served
to strengthen the global disease surveillance network infrastructure.
u Existing networks form a significant infrastructure that can be leveraged
and built upon in future grants. Measuring existing network ties from
GOARN and other sources may help the Foundation strategically identify
1) gaps in network coverage, 2) portions of the network highly dependent
on a subset of organizations, and 3) potential key players having ties to
target organizations.
The following two figures show the changes in network ties as mapped
through data obtained in the Global Evaluation Team’s desk audit.
Organizations isolated without Rockefeller Foundation grantees (blue); Other organizations
(incl. MBDS) (red). Excluding: 1) Countries and country links 2) Isolate organizations without
country links. Note that several organizations are isolated from the existing network.
Figure 3. Global Outbreak and Alert Response Network
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Policy Influence
Initiative 
Contribution
Rockefeller Foundation global grantees (large blue); Organizations incorporated by RF
grantees (small blue); GOARN organizations (including MBDS) (red); Excluding: 1) Coun-
tries and country-organization links, and 2) Organizations isolated without these links.
EVALUAT ION  QUEST IONS  
To what extent have policy frameworks been created that have reduced
fragmentation in the Mekong region and East Africa?
How have health policies harmonized across countries in the region?
How has the MBDS example influenced other network policy initiatives
in other parts of the world?
To what extent are there specific new plans to influence policy in the
member states, in the regions, globally? 
Are there examples that demonstrate how the Initiative affected policy
or improved practice in member countries in the regions involved? 
To what extent has the DSN Initiative expanded the policy capacity of
network participants?
To what extent has the Initiative broadened policy horizons?
Figure 4. Global Outbreak and Alert Response Network
4.3.4 
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The analysis of the DSNs overall policy influence used a policy cycle diagram
to analyze the policy work of the DSN Initiative (Figure 5). Based on the
analysis of the Initiative documents the Initiative’s policy influence extends
from agenda setting (eg. One Health) to policy options for the way informa-
tion is shared between countries and network participants, to topics affecting
national, regional, and to global policy agendas, and policies that are estab-
lished to integrate human and animal health sectors. Different grants in the
portfolio influence different quadrants of the diagram, in their respective pol-
icy spheres. 
The global health diplomacy grants mainly fall into the Agenda Setting quad-
rant, with activities focused mainly on getting global health diplomacy onto the
policy agenda for individual countries as well as the global policy stage. Memo-
randa of Understanding between countries, describing how information will be
shared between them, lay in the policy implementation quadrant, and so forth.
Policy 
evaluation
Problem 
identification
Policy 
enforcement
Policy 
accountability
Agenda
setting
Policy
research
(Policy options
and strategies)
Policy 
negotiation
Policy 
formulation
(Policy organization)
Policy 
implementation
Policy Review Agenda Setting
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Figure 5. Policy Cycle Diagram
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Findings
u On the global level, the DSN Initiative has propelled One Health,
regional disease surveillance networks, and global health diplomacy onto
the policy agenda. The work in One Health and networks has moved
through the policy cycle the farthest, both well into the implementation
quadrant. US agencies and WHO regional frameworks such as APSED
have incorporated One Health into the core of their work. There are still
opportunities to develop One Health in terms of education policy, as some
stakeholders and grantees believe that to have effective One Health collab-
oration practitioners need to be trained together. Regional networks and
the policies necessary to support them are active in Africa and Asia. Global
health diplomacy falls into the agenda setting quadrant at this early stage
of development.
u Although in the Mekong region evaluation report, MBDS was not viewed
as having a significant effect on formal policy frameworks, where it is
active, especially at cross-border sites, its implementation demonstrates
that there have been changes in policy and procedures that allow for infor-
mal information exchange. 
u The evaluation team found little evidence in publications in the white or
gray literature or on participating ministry of health (MOH) websites that
health policies have harmonized across the Mekong region through the
MBDS process. This remains to be done. 
u Experience with MBDS has contributed greatly to the development of the
Southern African Centre for Infectious Disease Surveillance (SACIDS).
Within the first six months of operation, SACIDS was able to create a
governance structure, standard operating procedures and a plan-of-action.
DSN Initiative partners are working to make another regional network
active in South Asia, and there is interest in the Pacific to review the
MBDS model for adaptation in that region.
u Principles and ideas developed through meetings, such as Bellagio, are to
be taken back to the participants’ own communities, companies, govern-
ments, and universities to influence the creation of local initiatives.
u Grantees in the Mekong region have undertaken needs assessments for
capacity building in the use of information technology. The grantees have
made recommendations about educational curricula that could be used in
policy development. Grantees also plan to hold trainings and symposiums
to get their respective topics onto policy agendas globally and nationally.
u Thailand is a good example where practices have started to change to
incorporate the One Health concept. There, policy makers from both
human and animal health ministries meet on a regular basis, and they are
also working with the agricultural and wildlife sectors.
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u Grantees report having been part of discussions regarding global disease
detection, surveillance, and biologic threats, working with the National
Security Council, the Nuclear Threat Initiative and other groups to share
lessons learned. Network experiences have been used to inform the United
States’ decision making on global disease surveillance in terms of increas-
ing international cooperation, deterring bio-weapon use, and building bio-
safety, bio-security and trust.
u New policy horizons have been generated through convening difference
actors, drawing from the expertise of a variety of grantees and introducing
new fields of practice. 
Discussion
See further discussion of policy influence in the Discussion and Summary
section of this report. 
Capacity
Findings
u The DSN Initiative is, at its core, a capacity building endeavor. While
capacity building is central to all outcome areas, a lack of concrete meas-
ures and mapping of capacity building inputs and results limited a com-
prehensive evaluation of the full extent of achievement of capacity
building efforts. 
u Early grants in the Mekong region were used to determine the capacity
needs of the region and grantees were selected who would help build
capacity through their grant activities by transferring knowledge to local
practitioners.
EVALUAT ION  QUEST IONS  
To what extent does the Initiative include capacity building, training,
and implementation?
Is there a capacity building strategy, workplan and resource plan? 
To what extent have changes occurred in knowledge, attitudes, policies,
or practice in the behaviors, relationships, activities or actions of the
people, groups and organizations with whom the DSN Initiative is
involved?
To what extent have desired capacity change outcomes at the individual,
institutional, network and policy levels occurred?
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u Every grant in the sample of global grants, and many in the regional sam-
ple, encouraged capacity building through improved communication, skill
building or resource sharing. 
u Capacity outcomes have been achieved to a significant degree. Workshops
were offered, curricula and tools developed and individuals were trained in
their use. Forums were created that allowed knowledge sharing and best
practice development. Plans for laboratory, human resource, and techno-
logical capacity were included in many grants in the portfolio. Practice and
skills have visibly improved, and the result of improved capacity is evident
at cross border sites in the Mekong in improved response times, sharing of
information, etc. (see Mekong Region Evaluation Report)
u Change at many levels has occurred to a great extent. Broad changes asso-
ciated with DSN activities include interaction between sectors and net-
work participants, a wider acceptance of informal disease information
sources, acceptance of One Health principles by a broad range of stake-
holders and increased awareness that global health is a foreign policy topic.
u Networks have evolved over time and can now be used to exchange
resources as well as information, and joint trainings between animal and
human health practitioners and multinational trainings are occurring.
Discussion
See further discussion in the Summary and Discussion section of this report.
Research Capacity
Findings
u The grantees involved in the emerging field of Global Health Diplomacy
recognize the need to establish a literature base and have prioritized
research as a focus area, crossing the health and diplomacy disciplines, and
publishing articles emphasizing the importance of the subject matter.
u Work performed by One Health grantees became the nexus of USAID’s
RESPOND work.
n Findings
4.3.6 
EVALUAT ION  QUEST IONS  
Has the network fostered research collaboration between countries or
across disciplines?
Have there been changes in organizational capacity to do research?
Has the networking in the two regions created additional capacity?
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u The literature review performed by the evaluation team revealed very 
few publications related to DSN Initiative funded activities. One Health 
is a topic area that has seen an increase in the number of articles pub-
lished. Many of the articles are technical in nature and written by animal
health experts.
u The Mekong region evaluators found little evidence of increased research
collaboration, except in performing joint outbreak investigations.
Discussion
There was very little evidence of direct increases in research collaboration or
capacity. Indirectly, however, the increased collaboration introduced in the
global forums for food security, global health diplomacy, and regional net-
works have potential to lead to new research opportunities and collabora-
tions. The DSN Initiative is not a research initiative, however some applied
research was performed, and researchers were included in some grant activi-
ties. While traditionally the work undertaken through the DSN network
funding area is not reported in academic literature, the innovative work
would make a valuable contribution to the literature. The Rockefeller Foun-
dation could increase the influence and reach of its DSN grantmaking if it
required or incentivized publication of results by grantees. 
Influence on Technology
Findings
u Current technology was adapted to improve communication between
broadly dispersed stakeholders, For example, websites and wiki pages were
used by grantees to aid in information sharing. Development of web-based
training modules aimed to improve the number of trainings offered, and
increase the accessibility of some trainings. 
u Networks place some emphasis on standardizing lab technology to unify
case definitions and protocol within a region.
u Data mining tools and mapping tools were utilized over the course of
grantee activities.
u Technology developments were not always taken up readily on the regional
level, and some global uses may not be fully accessed by potential benefici-
aries because of cultural and language barriers. 
n Findings
EVALUAT ION  QUEST IONS  
Has the DSN Initiative brought forward technology development, 
adoption or adaptation in the two regions where it is active?
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Discussion
Tools were developed for use within the Mekong region and globally. As dis-
cussed in the Mekong region evaluation report, different areas in the region
have varying technical and cultural capacities to adopt the tools offered.
Grantees are aware of the benefits of technology, but in some areas, it takes
significantly more time for technology to be adopted and integrated into reg-
ular use. In addition, the benefits of use may need to be made more explicit
to users because they have not built up the intuition to know how to fully
utilize technology when it is made available to them.
Sustainability
Findings
u Sustainability remains an issue for networks in Asia and Africa, primarily
MBDS in terms of institutionalization, and SACIDS in relation to its
early stage of development. The Africa and Asia DSN Evaluation reports
discuss in detail the sustainability issues of the DSN Initiative work in
both regions. 
u The Global Evaluation found broad recognition for the need for institu-
tional independence of disease surveillance networks to ensure ongoing
transparency, engagement of key stakeholders, and building of trust among
key stakeholders.
u Informants raised a number of factors impacting grantees’ sustainability,
including planning, flexible support for innovation, and the complexity of
issues and jurisdictions. The development of governance models, ongoing
business plans, and funding exit strategies should have been undertaken by
DSN grantees at an earlier stage in the Initiative.
u The timing of phasing out funding was repeatedly mentioned by key
informants and grantees alike as being simultaneously a factor in the 
EVALUAT ION  QUEST IONS  
To what extent have MBDS and SACSIDS developed and implemented a
plan to become institutionally sustainable? 
To what extent have MBDS and SACSIDS developed and implemented a
plan to reduce dependency on donor funding? Are the plans realistic?
What is the probability of success?
Have new funding partners been recruited and are they now support-
ing MBDS and SACSIDS?
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success of new ventures, but also a challenge for donors to accurately
assess. Factors that were identified as influencing this timing included the
complexity of the activity, the progress of grantees toward grant goals, the
development of termination plans, and the availability of alternate funding
sources. In the case of specific entities such as MBDS, the complex multi-
country focus of the activity, the degree of innovation, and the significant
political and cultural changes required for progress were cited as barriers
requiring long-term commitments to solve.
u Our analysis identified several activities under development among
grantees for funding diversification:
u Attracting new funders
u The development of research as a fundable activity
u Levying fees from users/stakeholders (e.g. CHORDS)
u Self-financed course delivery
u Several concerns were raised by key informants that impact the potential
sustainability of grant activities. These included lack of coordination with
other funders such as USAID, the potential for a low dollar value to dis-
suade donors, and the difficulty using disease reporting activity as a metric
of institutional sustainability given the natural fluctuation in the incidence
of diseases.
Discussion
Assessing the sustainability of funded activities is of key importance in deter-
mining whether Rockefeller Foundation investments are catalyzing change.
The evaluation matrix focused on three questions on sustainability: plans for
sustainability, diversified funding and increased partnerships. While we found
broad evidence of efforts toward sustainability for all three questions, in
many cases these efforts have not yet matured.
The problem of financial independence is linked to that of institutional sus-
tainability and partnerships. Planning for alternate funding sources or other
funding models is closely connected to organizational planning and the
development of close partnerships, such that DSN programs are delivering
value to their partners and the global community. Examples of this value
mentioned by our informants include expansion into fundable research activ-
ities, the development of a fee-based model for expert consultation through
CHORDS, and self-financed courses. 
The current global economic climate makes diversification of funding sources
imperative for the ongoing success of DSN grantee programs. Although 
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alternate funding partners have been identified in some cases, at least one is
itself also funded by the Rockefeller Foundation. The 2010 Rockefeller
Foundation Grantee Perception Report (GPR)4 finds that while DSN
grantees received a relatively high proportion of their budgets from the Foun-
dation, 86 percent of grantees connect with other organizations to scale up
their work, while 69 percent “bring other investors into [their] program to
create leverage of existing work.” In both cases, these exceeded the average of
other Foundation grants, even though DSN grantees received less active sup-
port on average for securing outside funding. 
Several programs, such as ProMED, CHORDS, and MBDS, by their nature
are inherently collaborative and inter-institutional. As these organizations
move forward, they must expand their governance and cooperative relation-
ships to ensure financial sustainability. The Rockefeller Foundation, in turn,
should help these organizations realize development plans that reward inde-
pendence while giving them adequate time to achieve grant goals.
Impact
Findings
u The DSN Mekong Evaluation finds evidence of improvements in surveil-
lance systems, coordination and information sharing leading to improved
response times and containment of the spread of highly pathogenic infec-
tious diseases that in turn saved lives and livelihoods in Mekong region
countries. 
u Many effects and impacts of the Initiative are still maturing, but are recog-
nized by stakeholders as influential in bringing about positive changes in
practice. Examples include improving evaluation know-how in developing
countries to provide a valuable knowledge hub and improve systems, and
the potential for grantee activities to improve food safety in developing
countries, if fully implemented. 
u More reports are being made through ProMED, increasing the amount of
knowledge that is shared between countries, and changing the experience
of transborder disease information exchange. Less blaming and more coop-
eration and trust have emerged.
u Although a minority view, one stakeholder indicated that changes to pro-
tocol adherence hasn’t improved, that there is poor coordination of care for
ill people who cross borders, and that there is still a divide in terms of
resources between countries, so people will cross borders from a resource
poor country to receive treatment in a neighboring country.
u Networks and global health diplomacy are seen as valuable instruments
that increase the peace and stability of the regions in which they are active.
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This impact area was anticipated, but has received considerable attention
from scholars. The benefits of trust between countries were recognized
throughout the evaluation. 
u One Health has been integrated into activities in a limited way, and there
is still segregation between the animal and health fields. 
Discussion
In general, we found evidence in the Global and Mekong region evaluations
that the DSN Initiative is making an impact on the target regions and popu-
lations. However, challenges still exist for cross-border treatment and collabo-
ration between human and animal sectors that may require additional efforts.
Impact may require more time before it is fully realized. Details are presented
in the reports of the Mekong region and the Africa region on how the lives
of the vulnerable, trans-border disease transmission, and the supporting sys-
tems upon which they depend on were improved by the DSN Initiative.
The peace-building aspects of networking, and the way networks contribute
to global health diplomacy, is discussed at length in a forthcoming book,
Pandemic Peace by William Long of the United States Peace Institute. Dr. Long
elaborates on the value of regional networks, and is a strong proponent of
using such models to answer the other pressing problems of our day, such as
climate change and counter-terrorism. 
Management and Governance
Two dimensions of management and governance were assessed: the Founda-
tion’s role in the management of the DSN Initiative and the grantees role in
network management. Questions regarding the Foundation’s role in manage-
ment and governance were addressed through the desk audit and through
interviews with Foundation managers and grantee interviews. Questions per-
taining to the management practices of grantees were addressed partly through
the desk audit, but more specifically in regional evaluations.
Management of DSN Networks
Findings 
u Significant change has taken place in the model of operation and manage-
ment within the Foundation with the shift to an initiative model of opera-
tion. Grantees are sometimes confused about whom to interact with at the
Foundation because of transition in leadership or staff turnover. 
4.6 
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u Discussions with grantees suggest that they are aware of the importance of
management and governance structures in their respective areas of work,
and focus attention on developing such structures for the global networks.
There are, however, unresolved governance issues for some of the networks
(MBDS in particular). 
u While grant reports were a main source of information regarding grantee
management practices, the lack of standardization of grant reports made
this task challenging. 
Discussion
In 2006, the model of operation in the Foundation shifted to a time-limited
initiative model, with portfolio of grants under a number of large global 
initiatives. The portfolio framework is intended to provide a higher level of
consolidation of grants to achieve greater impact. In addition, teams in the
Foundation are expected to work across a number of initiatives providing a
challenging model of management of staff capacity to meet the ambitious
goals of the Foundation. While there is strength in more people working
across initiatives to prevent silos, it appears to be challenging to make the ini-
tiative model work effectively. The Evaluation Team had limited exposure to
other teams in the Foundation, however the DSN staff capacity is limited for
the large workload of the Initiative, and the staff seem stretched. 
Further improvements are recommended to make the management model of
initiatives even more effective. Meetings such as the regular Foundation Ini-
tiatives Meeting, and the Initiative Management Team, could be better uti-
lized, and records within the Foundation could be more complete and more
accessible. 
Monitoring Learning and Evaluation
Findings
u A monitoring plan was incorporated into the DSN Initiative proposal to a
fair extent, and in theory the progress of the Initiative is tracked with
respect to various outcome areas and assessed periodically in terms of
progress. However, the Global Evaluation Team observed that in reality the
practice is sporadic and should be more systematic. 
u As part of the results based management work of the Foundation, grants
were mapped to outcomes, and this provided a good analysis of the extent
of resource allocation according to desired outcomes. 
u A value map was originally proposed to link investments in the DSN 
Initiative to the outcomes, but this was not developed as planned.
Final 
Evaluation:
Global
49
n Findings
u Indicators and metrics were identified to monitor the grantees work. For
example, the number of published reports, local reports, translated reports
and veterinary reports could be used to monitor improvements in report-
ing from ProMED. Possible metrics for tracking changes for global health
diplomacy meetings include activities, level of connectivity, outcomes and
needs, and the number of resolutions outside the realm of public health
that contain health-related provisions.
u Most grantees did not conduct a formal evaluation of their grant.
Discussion
The importance of monitoring, sharing lessons learned, and evaluation is
well recognized within the Foundation. The DSN Initiative was one of the
first to come to an end and conduct a final evaluation. We recommend that
the Foundation develop a formal monitoring and evaluation process for all
the grants/initiatives supported by the Foundation to better track the effec-
tiveness and impact of their investments.
Managers at the Foundation emphasized the importance of incorporating peo-
ple with experience working with networks into both the planning of the
work and the evaluation process. This was borne out with our own network
studies of the portfolio and will be reflected in our strategic recommendations.
Most DSN grantees have some sort of monitoring system, but no formal
evaluation plan. A systematic capture and analysis of the utility of proposed
metrics would be a useful future contribution of the DSN Initiative given the
diversity of grants. Mandating that an appropriate monitoring and evaluation
plan be implemented by grantees in the future may allow the Foundation to
learn more systematically throughout the life of an initiative rather than wait-
ing until the end of the initiative. 
Risk Management
Findings 
u The Foundation managed programmatic risk of the DSN Initiative to
some extent. This could be strengthened going forward. Potential risks
were identified in the background documents, and various questions that
would mitigate these risks were listed and planned to be addressed, but
based on documents available, this was done only at a cursory level.
u The Foundation is incorporating risk management to a greater extent 
in future activities. It has been exploring the use of risk assessment
methodologies including risk profiles for portfolios to estimate reputation
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risk, execution risk, resource consumption, etc. Using the portfolio con-
cept, risks could be aggregated up to the Foundation level, and the risk
distribution could be calculated and set across the Foundation. Addition-
ally, recent changes made to the grant approval process include greater
consideration of risks. 
u Grantees included risk management in their formal submission to a mini-
mal extent, however no risk management practices were mentioned specifi-
cally in our data sources.
Discussion
Integrating a more formal risk management protocol for grants is relatively
new in the Foundation, and we recommend that the Foundation continue to
strengthen its assessment and management of risk. The results from testing
various risk assessment strategies can be used to develop a plan that best fits
the Foundation’s needs and can be applied to the development of all future
initiatives.
More detail on grantee risk management practices may be provided through
regional evaluations. In order for a grant to be implemented and completed
successfully, it would be beneficial for the Foundation to ensure that the
potential risks are identified and risk management practices are in place. 
Efficiency
Findings
u Comparative allocation figures for the portfolio by outcome area are lim-
ited to updates created for the Board of the Foundation. The last update
reviewed in the evaluation was 9/15/2010.5 That report indicates a total of
$17,227,360 in grants made: 29 percent ($5,052,773) for capacity building,
25 percent ($4,363,925) for networks, 24 percent ($4,036,739) for tools
and 17 percent ($2,874,464) for One Health leadership. An additional 5
percent ($799,960) has been awarded to “other”. Included in the briefing
4.7 
n Results
5 “Update on Progress in Grantmaking Disease Surveillance Networks, November 2010. 
EVALUAT ION  QUEST IONS  
To what extent are the resources used to achieve outcomes allocated
based on DSN priorities? 
To what extent were Foundation funds used catalytically to propel policy/
best practice/theory forward? 
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document is a year by year break down by outcome area of expenditures
which is consonant with the grant mapping by chronology carried out by
the Global Team. 
u In the outcome areas the pattern has been:
u A consistent rise over time in allocation for capacity building.
u A high proportion for networks with a dip in 2008, likely reflecting the
move of the portfolio to Sub-Saharan Africa.
u A rise in “One Health leadership” until 2008, with a sharp decline through
2009 and 2010.
u A relative high in investment in “tools” in 2007, with approximately equal
investment in 2008 and 2009 and a lower investment in 2010.
Thus, in sum, there appears to be less investment currently in One Health
and consistent investment in capacity development and networks.
u Shifts in DSN priorities and resource allocation have been responsive to
and reflected gaps in global disease surveillance processes, as demonstrated
in this quote from a key informant, which was echoed by several experts in
diverse disciplines: “There has to be health diplomacy in the mix because
although we can convince the technical people, they do not define the
country’s policies, thus health diplomacy is needed.”
u Another emphasis in this reporting is the identification of types and loca-
tion of grantees and the percentage of investment to them. Grantees are
classified as:
u developing country grantee
u developing country grantee with re-granting to developed country institutions
u grantee in developed countries to re-grant to developing country 
grantee partners
u grantee headquartered in a developed country with work conducted through
grantee’s office in a developing country
u developed country grantee to benefit developing countries
u developed country grantee to benefit developed countries, and finally
u international organization grantee. 
This analysis reflects a 50 percent investment in developing country
grantees overall, but only a 13 percent investment in 2010 to date which
does not seem to fulfill the stated principle of the Foundation to increase
its grantmaking to developing country institutions. 
u When the Initiative team mapped their outcomes for the evaluation, 
they mapped an investment of $16,085,170 of which they mapped 22
percent ($3,719,089) to collaborative alliances, partnerships and networks, 
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27 percent ($4,387,687) to increasing capacity, 23.9 percent ($3,845,489)
to outcome innovations and tools, and 19 percent ($3,067,386) to trans-
disciplinary leadership in One Health. The balance, 6 percent
($1,065,520) was mapped as “other”.
It is encouraging to note the proximity of the overall investment plan to
the actual investments reported to the Board as shown below:
It appears that the priorities and resourcing of the Initiative has been
maintained despite changes in staffing within the Initiative. 
u Little evidence is available to support the efficiency of use of grant
resources as measured by cost effectiveness. It would be possible to gener-
ate standard metrics for training courses by region, literature search activi-
ties, meetings, etc. and apply such metrics to future grantmaking, however,
these metrics are not available in the interim financial reports and other
documentation provided to the Global Team.
u The 2010 Rockefeller Foundation Grantee Perception Report (GPR) does
broadly address the size, progression and outcomes of DSN grants relative
to other grant recipients, as well as indicators relating to attracting outside
funding.
u Increased interactions with Foundation staff at several points in the grant
cycle (33 percent over average) likely impacted the efficiency of the grant
portfolio. At the outset of the grant cycle, Foundation staff involvement for
DSN grants was in the top 25 percent of all Foundation grants, and
grantees perceived more pressure to focus grant priorities on portfolio goals.
During the grant cycle, DSN grantees found reporting processes more help-
ful than other Foundation grantees, which were in the lower quartile. At
the end of the cycle, significantly more DSN grantees (78 percent) reported
discussing completed reports and evaluations with Foundation staff than
did other grantees (55 percent), despite an equivalent investment in Foun-
dation staff time spent on monitoring, reporting and evaluation processes.
u Organizations funded by the DSN Initiative had a smaller overall budget,
and larger median grant size than other Foundation-funded projects, there-
fore Foundation grants represented a larger percentage of their budget at 
n Results
Overall
Collaborative 
Alliances, 
networks
Capacity
Tools 
and 
Innovation
Trans-
disciplinary 
Leadership
Other
Mapped 22% 27% 23.9% 19% 6%
Reported 25% 29% 24% 17% 5%
4 2010 Rockefeller Foundation Grantee Perception Report (GPR), Centre for Effective
Philanthropy (CEP)
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14 percent vs. 5 percent for all organizations. However, despite receiving
less staff support to identify outside funding, DSN grants were more success-
ful at attracting outside funds. The Grantee Perception Report found that
Foundation support “[Brought] other investors into your program to create
leverage of existing work” for 69 percent of DSN grantees, versus 48 percent
for all Rockefeller Foundation grantees. This is consistent with reports from
grantee interviews. Specific outside funders leveraged by Foundation funds
included Google.org and USAID.
Discussion
One rationale for the DSN itself is that global disease surveillance is seen as
inefficient and uncoordinated. To the extent that the DSN sought to build
networks to address these problems, the efficiencies of Foundation grantmak-
ing may be viewed in terms of the effectiveness and sustainability of
increased coordination and the spread of best practices arising from grant
projects. It is in part through this increased efficiency that DSN grants were
intended to provide a large impact given the investment.
The resources invested in DSN were to a great extent responsive to opportu-
nities, lessons learned, and emerging needs in global disease surveillance. The
efficiency of this growth and development is difficult to gauge because of a
lack of measurable indicators. However, the evolution does show prioritiza-
tion of the key outcomes of the DSN Initiative, and changes in funding allo-
cations were directed toward outcomes that were gaining traction such as
One Health and global health diplomacy.
Rockefeller Foundation funds have been utilized by grantees to fund new,
innovative work that has attracted diverse stakeholders, and that may lead to
new funding models through diverse new sources. While in many cases
efforts to attract these funds are ongoing in the difficult current funding cli-
mate, DSN grantees broadly agree that the Foundation’s support has been
helpful to a great extent in helping them attract additional funds.
The DSN grants appear to have been broadly efficient in terms of individu-
ally aligning to Initiative priorities, leveraging the Foundation’s funds to pro-
mote ongoing work, and in utilizing staff input to guide outcomes. Less
evidence is available to support the collective efficiency of the portfolio strat-
egy, or the idea that the whole was more than the sum of its parts. However,
as ongoing developments and coordination take place between efforts in
MBDS, Africa, and the global coordinating team, further initiative-level effi-
ciencies are likely to occur. Furthermore, as global networks such as
GOARN, CHORDS, and GladNet mature, downstream impacts of Rocke-
feller Foundation funding will be in evidence.
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5. Conclusions and
Recommendations
The conception and execution of the DSN portfolio represents a centralscholarly contribution by the Rockefeller Foundation. If scholarship is
defined as the creation, teaching, integration and application of knowledge,
the portfolio crosses the spectrum handily. It represents a vibrant, diverse
body of work which has created new knowledge in the application of net-
working to promote ‘Smart” Global Health in developing countries, gover-
nance of sub-regional networks, elaboration and adoption of innovative IT
tools for surveillance and response, the significance of a trusted collaborative
social network in promoting transparency in disease surveillance and control,
and new theory in One Health and global health diplomacy. Teaching has
occurred in the traditional public health practice such as epidemiology and
laboratory investigation as well as in the innovative areas of informatics. The
application of learning through collaborative disease investigations and table
top exercises has occurred. The integration of multidisciplinary approaches
has been a guiding principle in the conception, design and execution of the
portfolio across two regions and globally. Continuing development of sys-
tems level approaches to complex problems is by nature iterative; as different
aspects take root and learning occurs it is worthwhile to reassess direction
and priorities, strategically applying the Foundation’s strengths most appro-
priately.
Two core observations of the Global Evaluation Team are: 1) The naming of
the Initiative as the ‘Disease Surveillance Network (DSN)’ under represents
the diversity and contribution of this body of work. It would more accurately
be labeled “a Community of Practice in Transnational Public Health.” In
fact, evaluation of this work through standard disease surveillance assessment
criteria would be inappropriate. 2) The winding down of funding for the 
Initiative may be premature, just as the value of the work is becoming widely
recognized in global public health practice. Prior to withdrawing from this
valuable body of work, the Foundation should invest in rigorously docu-
menting the achievements in the improvement of population health metrics
over time and in more fully integrating and analyzing the network mapping
across levels.6 
The Global Evaluation Team found the DSN Initiative to be a diverse and
highly effective grant portfolio. The historical work of the Foundation was
reflected in building increasingly relevant public health systems. The Founda-
tion excels at taking a systemic view of complex problems such as disease
transmission and surveillance, and contributed funding to practice areas to
address existing inadequacies from the local to global levels. 
6 The Global Team has developed a protocol for such a study. 
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The Foundation and its grantees leveraged the reputation and convening
power of the Foundation to accomplish tremendous work in networking,
capacity building, tools development, and establishing new fields of practice
in One Health and Global Health Diplomacy. The impact on peace, negotia-
tion, and collaboration between networked partners cannot be overlooked.
These networks have potential to solve complex diplomatic situations and
global problems through the base of trust established by informal interaction.
Of note in terms of influence in policy and practice, the recent USAID
Emerging Pandemic Threats ($400 million/5 years initiated 2009) is built
directly on work of Foundation grantees, and it cites that work in the pro-
gram and includes those grantees as current contractors. The Asia Develop-
ment Bank has modeled its Greater Mekong investment closely along the lines
of work pioneered by the Foundation. The One Health area is now invested
in by numerous donors based on the early work of the DSN Initiative.
At a global level, the appreciation of the importance of peer-to-peer commu-
nities of practice to promote trust in global public health is only now catch-
ing up to the thinking which created the DSN Initiative. As a developed
country top level official working in global disease control states, “When the
big one hits, we have found (developing country counterparts) turn first to
their informal networks.” Working in stove piped government bureaucracies
(as many ministry of health settings are) the responsible person can only con-
sult “up” or “down” the chain of command in country. Informal community
of practice networks provide a horizontal trusted alternative and trust build-
ing is evidenced throughout the networks in the portfolio. Cross country 
disease investigations epitomize this. When Hurricane Nargis hit Myanmar
with the loss of over 135,000 lives, teams from MBDS were allowed into the
country before other international experts based on the trust relationship
built through the DSN Initiative. 
WHO has used the term “network of networks” since 2001 to describe the
Global Outbreak Alert and Response Network (GOARN) for global disease
detection and response. That term, coined initially by the Asia Pacific Emerg-
ing Infections Network (APEC)/EINet in 2000 was based on the network
model which is exemplified now as CHORDS. While CHORDS struggled
with governance the group has now resolved to develop and set up an inde-
pendent secretariat outside of the United States within three years. The gen-
eral recognition of the importance of transnational communities of practice,
their potential contribution and the communications technologies to realize
them is only now becoming real. 
n Conclusions and Recommendations
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In terms of health diplomacy, as mentioned earlier an examination of the
work of the DSN Initiative (and other transnational initiatives) is soon to be
published by Dr. William Long in his forthcoming book, Pandemics and Peace
(publication pending, Peace Institute 2011), Dr. Long carefully sets the work
of the MBDS, East African Integrated Disease Surveillance Network and
CHORDS into the varied theoretical frameworks of foreign relations theory,
and examines the value added within that context. He concludes, “Using the
lens of political realism, we identify a shared compelling material interest in 
a transnational public good (protection from infectious diseases).” The foci
within the DSN Initiative, especially the promotion of South-to-South infor-
mal collaboration and cooperation, are in line with the State Department
emphasis on Smart Power and this theme is reflected in President Obama’s
Global Health Initiative (2011). 
The following recommendations are made by the Global Evaluation Team:
Key Recommendations
[1] The Foundation should continue to invest in transnational strategies as
well as country-by-country strategies, as the two are not mutually exclu-
sive and with increasing globalization transnational investment is essen-
tial to successfully assure “smart” globalization.
[2] The DSN Initiative contributed to the development of network strate-
gies in climate change resilience and other areas of the Foundation’s
work. Elements of existing DSN networks should be considered as valu-
able Foundation (and stakeholder) assets to be fostered through addi-
tional funding where needed, and to be extended to other portfolios of
investment. 
[3] Sustainability is the ultimate proof of added value, thus an exit strategy
for Foundation investment is of central importance. In particular foster-
ing thoughtful integration of key Mekong Basin Disease Surveillance
network elements with other efforts, such as the Association of Southeast
Asian Nations, Asia Pacific Strategy for Emerging Infectious Disease,
United States Agency for International Development, Asia Development
Bank and US Centers for Disease Control and Prevention, could help to
assure population security in the region for the longer term.
[4] As investment in some outcome areas of the DSN Initiative portfolio con-
tinues, revisiting the portfolio for a definitive summative evaluation using
the tools and metrics developed in this global evaluation will be of added
value especially in the areas of One Health and global health diplomacy,
the establishment of the South Asia network, the maturation and evolu-
tion of governance of Connecting Health Organizations for Regional Dis-
ease Surveillance, the transfer of informatics capacity, and the strategy for
institutionalization and sustainability of the MBDS network.
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[6] Given the South-South nature of collaborative networking efforts in the
portfolio, a greater emphasis on bilateral South-South negotiations
within the emerging realm of global health diplomacy, and a more
robust effort at inclusion of diplomatic and scientific leaders from the
South will enhance the utility of this new field.
[7] Encourage and support publishing and communicating the work of the
DSN Initiative and grantees. While global health diplomacy has prolific
publications, in other areas of the DSN Initiative increased publications
from grantees both in the peer reviewed and non-peer reviewed literature
would enhance the visibility and influence of the work. 
[8] Landscaping for prospective Rockefeller Foundation initiatives should
include detailed identification of stakeholders and indicators as well as a
theory of change. In particular population health metrics should be iden-
tified and modeled to where impact is anticipated through investment. 
[9] The Foundation should make explicit the expected synergies among
grantees towards the common vision of the portfolio. Convening grantees
is an important strategy in this regard. Experience with the DSN Initia-
tive suggests MBDS convening with other grantees during their sessions
and the initial Bellagio disease surveillance meeting was particularly fruit-
ful in this regard. Specific prospective network mapping and indicators
would assist this process. 
[10] While Disease Surveillance Networks has served as the title of this port-
folio, in fact the work has created Communities of Transnational Public
Health Policy and Practice in two regions and globally. Re-branding this
effort more accurately is worthy of consideration. 
We would like to commend the Foundation’s efforts at building evaluation
capacity in developing countries, and internally at the Foundation. There are
considerable strides being made within the Foundation that will address the
challenges the DSN evaluators faced during the course of work, including
improving accessibility to records and reports, formalizing learning mecha-
nisms within the Foundation, operationalizing evaluation and learning, and
establishing metrics to aid in ascertaining the impact of Foundation efforts.
Disease 
Surveillance
Networks
Initiative
58
Fidler D, Lee K, Smith R (2010). Global Health Diplomacy: A Conceptual Review. 
Internal report ID: 2010 DSN 304—Publication.docx, Rockefeller Foundation.
World Health Organization (2009). Proceedings Bellagio Global Health Diplomacy 
Dialogue Series Third Meeting. Internal report ID: 2008 DSN 315 Report on the 3rd
Bellagio Meeting (September 2009).
Wildlife Conservation Society (nd). Interim Narrative Report. Internal Report ID: 2009
DSN 301—Interim Narrative Report. Prepared for Rockefeller Foundation. 
Wildlife Conservation Society (nd). Interim Narrative Report Part 1. Internal Report ID:
2009 DSN 301 (Jan 2009–Dec. 2009). Prepared for Rockefeller Foundation. 
Wildlife Conservation Society (2008). Proposal. Internal Report ID: 2009 DSN 301 Wild-
life Conservation Society Proposal. Prepared for Rockefeller Foundation, 8 December 2008.
Wildlife Conservation Society (nd). Interim Progress Report. Internal Report ID: 2007 PAN
210 Wildlife Conservation Society Progress Report. Prepared for Rockefeller Foundation. 
Wildlife Conservation Society (2007). Proposal. Internal Report ID: 2007 PAN 210
Wildlife Conservation Society Proposal. Prepared for Rockefeller Foundation, 
4 October 2007.
Rockefeller Foundation (2007). Grant Agreement. Internal Document ID: 2007 PAN
206 IDSA ProMED Grant Agreement, 25 September 2007.
Infectious Diseases Society of America (2007). Continuation Project Proposal. Prepared
for Rockefeller Foundation, June 2007.
Rockefeller Foundation (2007). Grant Agreement. Internal Document ID: 2007 PAN
207 NTI Grant Agreement, November 15, 2007.
Nuclear Threat Initiative (2007). Proposal. Prepared for Rockefeller Foundation (nd).
Rockefeller Foundation (2009). Letter Granting Extension Request to NTI regarding 2007
NTI 207. Correspondence between Rockefeller Foundation and NTI, 8 April 2009. 
Infectious Diseases Society of America (2008). 2007 PAN 206 Interim Report
9/1/2007–9/30/08. Prepared for the Rockefeller Foundation, 31 October 2008.
Nuclear Threat Initiative (2009). Public Health Surveillance Networks: Learning, Trust,
Diplomacy, Science and Technology. Prepared for Rockefeller Foundation, 31 August 2009.
Nuclear Threat Initiative (2009). Correspondence to Rockefeller Foundation, 
31 August 2009.
Nuclear Threat Initiative (2008). Interim narrative Request for Extension. Correspondence
between NTI and Rockefeller Foundation, 9 September 2008.
Wildlife Conservation Society (2009). 2009 DSN 301 Wildlife Conservation Society
Letter of Request for Extension, 20 August 2009.
Rockefeller Foundation (2009). Letter Granting Extensions for 2009 DSN 301. Correspon-
dence to Wildlife Conservation Society from Rockefeller Foundation, 28 September 2009.
BIBLIOGRAPHY
Final 
Evaluation:
Global
59
Rockefeller Foundation (2009). 2009 DSN 304 Grant Agreement Letter. Correspondence
to Dr. Runte, Carleton University, 27 November 2009.
Rockefeller Foundation (2009). 2009 DSN 302 Graduate Institute Grant Agreement.
Correspondence to Graduate Institute from Rockefeller Foundation, 27 October 2009.
Nuclear Threat Initiative (2008). 2008 DSN 305 NTI Proposal. Prepared for Rockefeller
Foundation, 21 August 2008.
Regents of Minnesota (2009). 2008 DSN 304 Final Narrative Report. Prepared for
Rockefeller Foundation, 17 November 2009.
Rockefeller Foundation (2009). Letter Granting Extension re: 2008 DSN 304. Corre-
spondence between Rockefeller Foundation and Regents of Minnesota, 9 March 2009.
World Health Organization (2008). 2008 DSN 315 WHO Proposal. Prepared for 
Rockefeller Foundation, 8 October 2008.
Rockefeller Foundation (2008). 2008 DSN 315 WHO Grant Agreement. Correspondence
to WHO, 1 December 2008.
Rockefeller Foundation (2008). 2008 DSN 305 NTI Grant Agreement. Correspondence
to NTI, 2 December 2008.
Regents of Minnesota (2008). 2008 DSN 304 Regents of Minnesota Proposal. Prepared
for Rockefeller Foundation, 4 June 2008.
Rockefeller Foundation (2008). 2008 DSN 304 Regents of Minnesota Grant Agreement.
Correspondence to Regents of Minnesota, 21 August 2008.
Regents of Minnesota (2008). 2008 DSN 304 Regents of Minnesota Bellagio Participant
Final List June 2008. Prepared for Rockefeller Foundation, 6 June 2008.
Tufts University (2009). Correspondence to Rockefeller Foundation regarding Final
Financial Report for Grant 2007 PAN 211, 30 April 2009.
Asian Disaster Preparedness Center (2009). 2007 PAN 209 Extension Request. 
Correspondence to Rockefeller Foundation, 23 September 2009.
Asian Disaster Preparedness Center (2009). 2007 PAN 209 Asian Disaster Preparedness
Center First Interim Narrative and Financial Reports—March 2009–UNICEF CMAM
Proposal. Prepared for Rockefeller Foundation, March 2009.
Tufts University (nd). 2007 PAN 211 Tufts Summary and Synthesis Chapter to Final Nar-
rative Report. Prepared for Rockefeller Foundation.
Tufts University. (2007) 2007 PAN 211 Tufts Proposal. Prepared for Rockefeller 
Foundation, 24 October 2007.
Rockefeller Foundation (2007). 2007 PAN 211 Tufts Grant Agreement. Internal 
Document. Rockefeller Foundation, 15 November 2007.
Asian Disaster Preparedness Center (2007) 2007 PAN 209 Proposal. Prepared for 
Rockefeller Foundation, 5 October 2007.
BIBLIOGRAPHY
Disease 
Surveillance
Networks
Initiative
60
Rockefeller Foundation (2007). 2007 PAN 209 Grant Agreement Letter. Internal 
Document. Rockefeller Foundation, 30 November 2007.
Nuclear Threat Initiative (nd). 2007 PAN 207 NTI: Final Report–Public Health 
Surveillance Networks. Prepared for Rockefeller Foundation. 
World Health Organization (2009). 2008 DSN 315 Bellagio Global Health Diplomacy
Dialogue Series Third Meeting. Prepared for Rockefeller Foundation.
Carleton University (nd). 2008 DSN 302–Carleton University Grant for Health 
Diplomacy Publication. Prepared for Rockefeller Foundation.
World Health Organization (2009). 2008 DSN 315 Notes of Bellagio global health 
diplomacy 23-26 March 2009. Prepared for Rockefeller Foundation.
World Health Organization(2009). 2008 DSN 315 Summary Report on Bellagio Global
Health Diplomacy Dialogue Series Second Meeting. Prepared for the Rockefeller Foundation.
Rockefeller Foundation (2009). Internal Memo from Kate Bond to Darren Walker, et al.
Bellagio Health Diplomacy Dialogue Series, 25 October 2009. 
International Society for Infectious Diseases (2009). 2007 PAN 206 Interim Report
10/1/08-9/10/09. Prepared for the Rockefeller Foundation, 31 October 2009
Rockefeller Foundation (2006). Internal Memo from Kate Bond to Judith Rodin, 
12 December 2006.
Rockefeller Foundation (2009). Press Release: Promoting Trans-national Collaboration in
Disease Surveillance and Control, 28 April 2009.
Rist R, Morra Imas L. The Road to Results. 2009. The International Bank for Recon-
struction and Development/The World Bank, accessed through Rockefeller Foundation
SharePoint website, February 2011.
Bond K, Namuddu K, Puentes R (nd). Looking at Our Worth Through a Network Lens.
Internal Document. Rockefeller Foundation, accessed through Rockefeller Foundation
SharePoint website February 2011.
Bryce J, Victoria CG, Habicht JP et al (2004). The Multi-Country Evaluation of the
Integrated Management of Childhood Illness Strategy: Lessons for the Evaluation of
Public Health Interventions. Am J Public Health, 94(3):406-15.
Calain P (2007). From the Field Side of the Binoculars: a Different View on Global
Public Health Surveillance. Health Policy and Planning, 22:13-20.
Carande-Kulis VG, Getzen TE, Thacker SB (2007). Public Goods and Externalities: 
A Research Agenda for Public Health Economics. J Health ManagPract, 13(2):227-32.
Creech H, Ramji A (2004). Knowledge Networks: Guidelines for Assessment. 
Winnipeg, Manitoba: International Institute for Sustainable Development.
BIBLIOGRAPHY
Final 
Evaluation:
Global
61
Cross JE, Dickmann E, Newman-Gonchar R, Fagan JM (2009). Using Mixed-Method
Design and Network Analysis to Measure Development of Interagency Collaboration.
Am J Eval, 30(3):310-29.
Horelli L (2009). Network Evaluation from the Everyday Life Perspective. Evaluation,
15 (2):205-23.
Keeling M and Eames K (2005). Networks and Epidemic Models. J.R. Soc. Interface,
2:295-307.
Kimball AM, Moore M, French HM et al (2008). Regional Infectious Disease 
Surveillance Networks and their Potential to Facilitate the Implementation of the 
International Health Regulations. Med Clin N Am, 92:71.
Lescano A, Larasti R, Sedyaningsih E et al (2008). Statistical Analyses in Disease 
Surveillance Systems. BMC Proc, 2 Suppl 3:S7.
Luke D, Harris J (2007). Social Network Analysis in Public Health: History, Methods
and Applications. Annu. Rev. Public Health, 28:69-93.
Martinez-Lopez B, Perez AM and Sanchez-Vizcaino JM. Social Network Analysis.
Review of General Concepts and Use in Preventive Veterinary Medicine. Trans-boundary
and Emerging Diseases, 56:109-20.
May L, Chretien J, Pavlin J (2009). Beyond Traditional Surveillance: Applying 
Syndromic Surveillance to Developing Settings-Opportunities and Challenges. BMC
Public Health, 9:242.
Perry HN, McDonnell SM, Alemu W et al (2007). Planning an Integrated Disease Sur-
veillance and Response System: a Matrix of Skills and Activities. BMC Medicine, 5:24.
SEARO (2003). Regional Strategic Plan for Integrated Disease Surveillance 2002-2010.
New Dehli: WHO.
WHO (2001). Protocol for the Assessment of National Communicable Disease Surveillance
and Response Systems. Part 1: Guidelines for Assessment Teams.
WHO (2001). Protocol for the Assessment of National Communicable Disease Surveillance
and Response Systems. Part 2: Questionnaires.
Yang CC, Sageman M (2009). Analysis of Terrorist Social Networks with Fractal Views.
J Inform Sci, 35(3):299-320.
Wilkins K, Nsubuga P, Mendlein J et al (2008). The Data for Decision Making Project:
Assessment of Surveillance Systems in Developing Countries to Improve Access to 
Public Health Information. Public Health, 122(9):914-22.
Rockefeller Foundation (2006). Averting a Global Pandemic: an Initiative in Development.
Background Document for RF Board.
Rockefeller Foundation (2009). June 2009 Docket–Disease Surveillance Networks 
Initiative in Execution. Internal Document.
BIBLIOGRAPHY
Annex A: Terms of Reference 
Disease 
Surveillance
Networks
Initiative
62
Introduction 
This document provides an overview of the Scope of the Global Evaluation of the Rockefeller
Foundation’s Disease Surveillance Networks (DSN) Initiative to be undertaken during the
period of August 2009 through December 2011. 
Purpose and Objectives of the Evaluation 
The purposes of the evaluation are learning and accountability: 
[1] Learning from the achievements and lessons of the DSN Initiative to inform the future
work and strategies of the Foundation, it’s initiatives, grantees, partners and stakeholders,
and to contribute learning and knowledge to the fields of disease surveillance and public
health.
[2] Accountability to the Board of Trustees of the Rockefeller Foundation for the funds
invested in the DSN Initiative. 
The main objectives of the global evaluation and its component studies are: 
[1] To assess the relevance, effectiveness, efficiency, impact and sustainability of the Rocke-
feller Foundation’s support to the Disease Surveillance Networks Initiative.
[2] Assess the underlying hypothesis of the Initiative that robust trans-boundary, multi-sec-
toral and cross-disciplinary collaborative networks lead to improved disease surveillance
and response. 
[3] Make forward looking recommendations to the Foundation on:
a. The implications of the achievements, challenges and lessons from the DSN Initiative
for the strategy and investments of the Rockefeller Foundation at a global and region
level. This could include lessons for specific fields of work (health, urban, climate, etc.)
as well as lessons for Initiatives and grantees that aspire to build and sustain networks,
build capacity, and change policy globally, in Asia and in Africa. 
b. priority linkages and synergies for DSN learning to benefit the work of other initiatives,
regional offices, and key partners.
c. key priorities for funding and partnerships to sustain the gains made by the Foundation
in the field of disease surveillance networks. 
d. other implications as identified. 
The evaluation also aims to contribute to the field of philanthropy by demonstrating the use
of evaluations in grant making, learning and knowledge management, and by informing the
field of development evaluation about methods and models to measure complex networks.
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Components of the Evaluation (2009-2011)
[1] A summative and prospective evaluation of DSN Initiative work in the Mekong region 
(to be conducted by SEAMEO-TropMed) 2009-2010
[2] A summative and prospective evaluation of DSN Initiative work in Eastern and Southern
Africa (grantee to be determined). Late 2010
[3] A summative and prospective global evaluation of the DSN Initiative (to be conducted by
the Lead Evaluation Grantee). 2010–2011
Background Context for the Evaluation
In 2008, the Board of Trustees of the Rockefeller Foundation approved $21.3 million in sup-
port for the Disease Surveillance Networks Initiative with the aim of achieving the following
objectives:
[1] Improve human resources for disease surveillance in developing countries, thus bolstering
national capacity to monitor, report and respond to outbreaks;
[2] Support regional networks to promote collaboration in disease surveillance and response
across countries; and
[3] Build bridges between regional and global monitoring efforts.
The intended outcomes of the Initiative are: 
u Improved competencies (skills, capacities) in the Greater Mekong Sub-region and 
Eastern and Southern Africa to conduct disease surveillance and response efficiently
and improve capabilities in trans-border collaboration across countries;
u Global collaboration and learning among regional disease surveillance networks 
worldwide; and
u Collaboration between regional disease surveillance networks and international agencies
to increase the efficiency of global systems for disease surveillance and response.
Of the total $21.3 million, $6.2 million in grants were awarded during the development phase
of the Initiative in 2007, and another $14.5 million in grants are to be awarded during the
execution phase of the Initiative (2008–2011). 
Audience and Users of the Evaluation 
The Evaluation is commissioned by the President and Executive Team of the Rockefeller
Foundation and managed by the Foundation’s Evaluation Office. 
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The primary audience for the evaluation (i.e. those who are expected to act on the findings
and recommendations) is the President, the Board of Trustees of the Foundation, the Execu-
tive Management Team and the Managers of the DSN Initiative. Secondary audiences are the
DSN grantees, partners and other funders in the field of disease surveillance. 
Key Performance Areas—Evaluation Questions 
The key performance areas and evaluation questions to be covered in the evaluation, including
its regional evaluation components are outlined in detail in the Evaluation Matrix included in
the Annexes (see Data Collection Annex). The main performance areas to be covered are: 
[1] Relevance—including rationale, niche, role, comparative advantage and value added of
the Initiative. 
[2] Effectiveness—an assessment of the results of the Initiative, including:
u The quality and utility of the products and services planned and provided.
u The changes or outcomes that have occurred, as well as the impact the Initiative has
had on people and systems. 
u The extent to which the Initiative built capacity at the individual, institutional and net-
work level,including an analysis of the extent to which the strategy of the Initiative con-
tributed to better detection and management of disease outbreaks in the regions of focus. 
u The degree of influence that the Initiative has had on policies, public discourse, and
practices in the fields of public health, disease prevention and development. 
[3] Cost effectiveness/Efficiency—an assessment of the use of resources to obtain results
(time, funds, skills). 
u The extent to which the Rockefeller Foundation is using best management and gover-
nance practices in DSN, and whether those practices providing good value for money?
This area covers strategy and planning of the Initiative, management and leadership,
relationship management with grantees, peers and partners.
u Management of the grant portfolio—picking the right grantees, assessing capacity,
developing and supporting, delivering results, use of and accounting for resources,
monitoring, evaluation and learning, and knowledge management (lessons learned,
sharing of information, knowledge). 
[4] Impact—an assessment of the impact that the Initiative has had on people and systems.
Ideally (provided there is monitoring and baseline data) this will include: 
u An assessment of the extent to which DSN has contributed to, or directly affected
improvements in the lives of poor and vulnerable people within the broader population
served by the work of grantees. 
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u An assessment of the impact of DSN on the systems upon which poor and vulnerable
people depend (environmental, social, economic, cultural, political, etc). 
[5] Sustainability—the extent to which the Initiative has developed both financial and/or
institutional supports to continue the work started by the Initiative. This will assess the
extent to which: 
u The efforts (outputs and outcomes) of the Initiative are embedded in ongoing practices
of people, institutions and communities. 
u The exit strategy for the Initiative creates a high probability of the main outcomes of
the Initiative continuing beyond Rockefeller Foundation funding.
u Expanded partnerships exist for scaling up the work, and sustaining the Initiative
beyond the Rockefeller Foundation’s support. 
Methodology
Mixed methods will be used to conduct the evaluation including grant portfolio reviews, 
interviews, field visits, surveys, desk studies, and focus groups. 
[1] An analytical review of the Portfolio of the grants funded under the DSN Initiative 
in the Mekong region, Africa region and globally. 
[2] Field visits to a purposeful sample of the DSN funded work of grantees. 
[3] Stakeholder interviews with:
u disease surveillance leaders, policy makers and practitioners in the Mekong Region,
Eastern and Southern Arica, and globally. 
u partner organizations and other funders in Asia, Africa and globally. 
u RF managers in Asia, Africa and RF New York. 
[4] Desk Review of documents—including grant documentation, regional trip reports, work-
plans, conference reports, financial reporting, budgets, monitoring reports, etc. 
[5] Other methods to be determined. 
The sampling strategy for in-depth review of grants, desk review, and field visits will be deter-
mined in the planning phase of the evaluations with the grantees. However, in general, sam-
pling will be purposeful, focusing on a selection of grants that explicitly state that they expect
to contribute to the objectives and outcomes of the Initiative. 
Management of the Evaluation—roles and responsibilities
The roles and responsibilities of the RF offices and grantees in managing and implementing
the evaluation are as follows:
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The Lead Evaluation grantee will be responsible for: 
u Ensuring qualified M&E grantees carry out the monitoring and evaluation work in the
Mekong region and Eastern & Southern Africa, collaborating with the Foundation’s
Regional Offices).
u Developing the TOR for the Mekong region and Eastern & Southern Africa in consultation
with the DSN Team, the Regional Offices and the Evaluation Office.
u Managing the workflow and activities of the evaluation components over the life of the grant.
u Delivering the agreed outputs in this TORs to a high level of quality and utility.
u Emphasizing capacity building, mentoring, coaching and learning in the approach to M&E
with the DSN participants. 
u The Lead Evaluation Grantee may also be asked to participate in reporting the results of the
DSN Evaluation to the Executive Team of the Foundation and the Board of Trustees.
Regional Evaluation Grantees
u Participating in the design of the Mekong and Africa Evaluation with the Lead Evaluator,
DSN Team, Asia and Africa Regional Offices. 
u Providing skilled and experienced evaluators to fulfill all areas of the TOR and Evaluation
Matrix (Note: Separate TOR and Evaluation Matrix will be developed for each regional
evaluation grantee, with input from the evaluation grantee, the Lead Evaluator, the RF
Regional Offices, the DSN Team, and oversight and sign-off by the RF’s Evaluation Office). 
u Conducting the evaluation according to high evaluation standards and ethics, including
data collection, analysis and reporting. (OECD Evaluation standards are followed by the
Foundation)
u Maintaining ongoing communication and liaison with the Lead Evaluation Grantee and RF
Asia and Africa Offices respectively, and throughout the evaluation. 
u Delivering evaluation products that are of high quality. 
u Reporting on the evaluation findings and conclusions in a suitable format for the range of
intended audiences. 
The Evaluation Office will be responsible for:
u Setting the standards for the DSN monitoring and evaluation work, based on international
best practice evaluation standards (OECD, international development evaluation).
u Overseeing the design of, and signing-off on, the TOR and Evaluation Matrix for the global
evaluation, and the evaluations of the Mekong region and Eastern & Southern Africa.
u Reviewing and signing off on the quality of all M&E products provided by the Lead Evalu-
ation Grantee and Regional Evaluation Grantees (matrices, workplans, evaluation methods,
interview protocols, sampling strategy, etc.).
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u Reporting the results of the overall DSN Evaluation to the President, Executive Team and
Board of Trustees of the Foundation, with the DSN Managing Director. The Lead Evalua-
tion Grantee may also be asked to participate in this reporting. 
The DSN Team and RF Asia and Africa Regional Offices will be responsible for:
u Providing input to the TOR and Evaluation Matrix for the evaluations in the Mekong
region and Eastern & Southern Africa.
u Providing ongoing operational guidance to the Lead Evaluation Grantee and regional evalu-
ation grantees.
u Providing administrative liaison for the global and regional evaluators with the DSN
grantee(s), including coordination of meetings and travel for the evaluation work. 
A small DSN Evaluation Advisory Committee may be appointed to review and advise on key
global and evaluation products (methodology, workplan, data analysis and findings, draft and
final reports). Members will be globally and regionally recognized DSN specialists and evalua-
tors. 
Qualifications of the Lead Evaluator and the Regional Evaluation Grantees
The Lead Evaluation Grantee will be a senior program evaluator with significant experience in:
program evaluation and in the field of disease surveillance at global and regional levels, man-
agement of large complex evaluations, and communication with diverse global and regional
evaluation audiences. 
The Regional Evaluation Grantees will be organizations with significant experience in program
evaluation and disease surveillance in the DSN countries of relevance in Asia and Africa
respectively. Teams will comprise members with demonstrated experience in the use of qualita-
tive and quantitative methods, survey techniques, inventory, observation and desk review, as
well as experience in epidemiology, health diplomacy, veterinary public health, information
technology, biostatistics and behavioral sciences. Regional grantees will assume responsibility
for the quality, timeliness and accuracy of deliverables for the regional evaluations. 
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Schedule
An initial schedule is presented below. The schedule will be further refined by the Lead 
Evaluation Grantee and the RF Evaluation Office in consultation with the RF New York and
Regional Offices, and with the Regional Evaluation Grantees. 
Terms of Reference: DSN Evaluation Advisory Committee (EAC)
A global Evaluation Advisory Committee (EAC) for the Global Evaluation of the Rockefeller
Foundation’s DSN Initiative was established to advise the Foundation’s Evaluation Office and the
Lead Evaluation Grantee, the University of Washington, on the quality of the evaluation design. 
The main objective of the EAC is to provide independent advice to ensure the objectivity of
the global and regional DSN evaluation components. 
Specifically, the EAC is expected to:
[1] Provide concise written reports on behalf of the Committee on the quality, credibility and
appropriateness of the global and regional DSN Evaluation products and process in three
major phases of the evaluation: 
a. Design phase—the methodology, workplan, and data collection strategy; 
Date Deliverables and Milestones
September 2009
u Lead Evaluation Grant awarded
u Initial Evaluation Matrix and Scope of Work refined for global evaluation 
September 2009 u Mekong Evaluation Grant awarded
September to
December 2009
u Initial planning for Mekong Evaluation
u Scope of Work refined, and Evaluation Matrix completed
u Evaluation team appointed.
January to
June 2010
u Mekong region summative and prospective evaluation conducted and reported 
June to
December 2010 
u Planning and conduct of East and Southern Africa DSN Evaluation
Through 2010 
u Global evaluation conducted at intervals throughout the year with key players
globally and at RF New York and Regional Offices
January to 
August 2011
u Complete global evaluation, synthesize regional findings and 
recommendations, report to RF at intervals
October to
November 2011 
u Final Evaluation Synthesis Report for Board reporting November 2011
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b. Implementation—data quality, analysis, preliminary findings, and the process of the
evaluation in relation to quality;
c. Reporting—draft and final reports of each component of the evaluation (Global, 
Asia, Africa). 
[2] Identify:
a. gaps in the evaluation design and process in relation to the TORs for the evaluation
pertaining to the field of disease surveillance and the broader strategic objectives of the
Foundation; and 
b. identify potential risks to the evaluation and/or to the Foundation resulting from 
evaluation work.
The Advisory Committee members are: 
u Dr. Zenda Ofir, PhD, Evaluation Specialist; Eval Net, former Chair of the African Evalua-
tion Association
u Dr. Gunael Rodier, Director of International Health Regulations, WHO (Now with WHO
EURO office)
u Dr. Somsak Chunharas, Secretary General, National Health Foundation, Thailand
u Dr. Oyewole Tomori, Vice Chancellor, Redeemer’s University, Redemption City, Nigeria
The Committee participated in two-day meetings in Bangkok with participants from the
Foundation’s offices in New York and Bangkok, the University of Washington, and SEAMEO
teams on January 31–February 1, 2010 (with the exception of Dr. Tomori, who was unable to
obtain a visa). In July 2010 the teams participated in individual conference calls with Zenda
Ofir, in which they discussed the EAC’s comments on evaluation design. The EAC continues
to provide assistance through supplementary meetings using video conference, conference calls
and emails.
Advisory Committee Terms of Reference: Objectives and Scope of Work 
of the Evaluation Advisory Committee
The main objective of the Evaluation Advisory Committee is to provide independent advice to
the Lead Evaluation Grantee and the Rockefeller Evaluation Office to ensure the independ-
ence and objectivity of the global and regional DSN evaluation components. 
Specifically the Evaluation Advisory Committee is expected to:
u Provide short written reports on behalf of the Committee on the quality, credibility and
appropriateness of the global and regional DSN Evaluation products and process in three
major phases of the evaluation: 
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a. Design phase—the methodology, workplan, data collection strategy; 
b. Implementation—data quality, analysis, preliminary findings, and the process of the 
evaluation in relation to quality; and
c. Reporting—draft and final reports of each component of the evaluation 
(Global, Asia, Africa). 
In doing so the Committee is asked to identify gaps in the evaluation design and process in
relation to the TORs for the evaluation pertaining to the field of disease surveillance and the
broader strategic objectives of the Foundation; and potential risks to the evaluation and/or to
the Foundation resulting from the work of the evaluation.
Composition and Qualifications of the Advisory Committee
The Advisory Committee shall be comprised of senior professionals who are recognized
experts in the following areas: 
u Evaluation of complex regional programs and networks, specifically with experience in carry-
ing outportfolio reviews, meta evaluation reviews, network evaluation, and quality assurance
u Assessment of disease surveillance systems, specifically in Asia and Africa
u Evaluation of the One Health approach 
u Evaluation of health policy and health diplomacy globally and regionally
u Knowledge of development issues and trends. 
Candidates must demonstrate:
u Commitment and availability to participate in meetings
u Extensive experience in evaluation in Asia and Africa, preferably in the Mekong countries
and countries in East and Southern Africa
u Experience in program evaluation in the areas of public health, animal and human health,
health policy, and development programs
u Free of conflict of interest—that is, candidates must not have current remuneration of 
any kind from the Disease Surveillance Initiative of the Rockefeller Foundation or any of 
its grantees.
In selecting candidates to join the Committee, there will be due consideration for the need for
geographic representation from Asia and Africa, and gender balance. A program evaluation
specialist will be the Chair of the Committee unless otherwise decided. 
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Meetings 
The Committee will be convened by the Managing Director for Evaluation. The Committee
will hold an initial face to face meeting in Bangkok, January 31-February 1, and will confer
after that primarily by video conference, phone conference calls and email to deliver the
expected evaluation advice. Details of the most appropriate form of communication among
the Committee members and with the Foundation and the Lead Grantee will be further devel-
oped at the first meeting of the Advisory Committee in Bangkok. The Committee together
with the RF Evaluation Director, the Lead Global Evaluator and the Lead Evaluator for the
Mekong Evaluation will discuss and agree a tentative schedule for the remainder of the work
of the Committee throughout 2010–2011. 
Communication and Reporting 
The Evaluation Advisory Committee will provide considered, deliberative expert evaluation
advice through the Chair of the Committee to the Director of Evaluation of the Rockefeller
Foundation and to the Lead Evaluator. The Director of Evaluation and the Lead Evaluator will
be responsible for sharing the advice of the Committee with the respective Mekong and Africa
Evaluation Teams, and RF managers as appropriate. 
To ensure clear communication lines, roles and responsibilities, questions from Committee
members should be directed to the Lead Evaluator and the RF Evaluation Director. 
In certain instances specific advice may be sought by the Lead Evaluator and the regional eval-
uation team leaders from individual Evaluation Advisory Committee members depending on
the expertise of Committee members and the needs of the Global, Mekong and Africa Evalua-
tion Teams. These arrangements will be agreed in advance in order to respect the limited time
available of the Advisory Team members. 
Documentation will be sent to the Committee at least a week before the meeting date. Time
will be allocated at the meetings for the Committee to prepare their written comments and
recommendations to be delivered at the end of the meeting itself. Other advice may be sought
from the Committee between meetings. 
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Deliverables of the Advisory Committee
The Advisory Committee will be expected to provide written comments and recommenda-
tions on the quality and adequacy of, and any necessary improvements to the:
[1] The products of the design phase—the methodology, workplan, data collection strategy; 
[2] The products of the implementation phase—data quality, analysis, preliminary findings,
and the process of the evaluation in relation to quality.
[3] The reporting products—draft and final reports of each component of the evaluation
(Global, Asia, Africa). 
[4] The overall synthesis report to President and the Board of Trustees of the Foundation. 
In doing the Committee is asked to identify gaps in the evaluation design and process in rela-
tion to the TORs for the evaluation pertaining to the field of disease surveillance and the
broader strategic objectives of the Foundation; and to identify potential risks to the evaluation
and/or to the Foundation resulting from the work of the evaluation.
Internationally accepted evaluation quality review standards will be used by the Committee.
(OECD, IOCE, Program Evaluation standards, meta review standards, etc.).
Prior to the first meeting of the Evaluation Advisory Committee the Committee will receive
the design, workplan and methodology for the Global Evaluation, and the Mekong Evalua-
tion. The Committee will be expected to provide comments on each of these products at this
first meeting. 
Remuneration and Performance 
Members of the Evaluation Advisory Committee will be provided with an honorarium for
serving on the Committee, provided they participate fully in the work of the Committee.
Members will receive reimbursement for economy travel and related expenses by the Lead
Evaluation Grantee, the University of Washington.
The participation and performance of members will be reviewed annually. Where performance
and/or participation on the Committee do not meet the requirements of the TOR and the
expectations of the Foundation and the Lead Grantee, members may be replaced at the discre-
tion of the Foundation and the Lead Grantee. 
Confidentiality 
The Committee will be required to sign a commitment of confidentiality as part of the letter
of agreement to serve on the Committee. 
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DSN Global Evaluation Team Members—University of Washington
ANN MARIE KIMBALL, MD, MPH, FACPM
Lead Evaluator
Director, Asia Pacific Economic Cooperation, Emerging Infections Networks
Professor, Epidemiology, Health Services, School of Public Health 
Adjunct Professor, Medicine (BHI and ID), School of Medicine 
Adjunct Professor, Henry M. Jackson School of International Studies 
Contact: email: akimball@u.washington.edu; tel: 206.616.1830
NEIL ABERNETHY, PhD
Network Analysis lead and Quantitative Methods Specialist
Assistant Professor
Division of Biomedical and Health Informatics, School of Medicine and
Department of Health Services, School of Public Health
Contact: email: neila@u.washington.edu; tel: 206.616.2813
SARA CURRAN, PhD
Technical Advisor for SEAMEO Network Analysis and Qualitative Methods Specialist
Associate Professor, Henry M. Jackson School of International Studies and
Daniel P. Evans School of Public Affairs
Contact: email: scurran@u.washington.edu; tel: 206.543.6479
MARY KAY GUGERTY, PhD, MPA
Program Evaluation Specialist
Associate Professor, Daniel P. Evans School of Public Affairs
Contact: email: gugerty@u.washington.edu; tel: 206.221.4599
EMIKO K. MIZUKI, PSYD, MBA
Project Manager/Administrator 
Program Manager, Epidemiology, School of Public Health and Community Medicine
Contact: email: emizuki@u.washington.edu; tel: 206.221.7658
SHANNON HARRIS, MPA CANDIDATE, MPH CANDIDATE
Project Coordinator/Research Assistant 
Masters of Public Administration Candidate, Daniel P. Evans School of Public Affairs 
Masters of Public Health Candidate, School of Public Health and Community Medicine
Contact: email: harris23@uw.edu; tel: 206.650.2428
DEBRA REVERE, MLIS, MA
Research Coordinator
Clinical Instructor, Health Services, School of Public Health
Contact: email: drevere@u.washington.edu; tel: 206.616.2728
ALICIA SILVA-SANTISTEBAN
Program Coordinator 
Health Services, School of Public Health
Contact: email: alicias@u.washington.edu; tel: 206.616.9244 
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DSN Global Evaluation Team Members—University of Washington
cont.
JANE (TSUNG-CHIEH) FU, MPH
Research Assistant
1st year PhD student, Department of Epidemiology 
School of Public Health
Contact: email: tfu@uw.edu
ANNE BUFFARDI
Research Assistant
Pre Doc Teaching Associate, Daniel P. Evans School of Public Affairs
Graduate, Public Policy Management
Contact: email: buffardi@u.washington.edu
CYAN JAMES, MFA
Research Assistant
2nd year PhD student, Institute for Public Health Genetics 
School of Public Health
Contact: email: cyanj@uw.edu
ABIGAIL VOGUS, MPA
Research Assistant, January 2010–June 2010
Daniel P. Evans School of Public Affairs 
Contact: email: vogusa@uw.edu
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DSN Mekong Evaluation Team Members—SEAMEO TROPMED Network
Ma. SANDRA B. TEMPONGKO, MPH, DrPH
Lead Evaluator
Evaluation and Public Health Specialist
Deputy Coordinator, SEAMEO TROPMED Network
Visiting Professor, College of Public Health, University of the Philippines Manila 
Contact: email: tmseanet@diamond.mahidol.ac.th; jolinatwoph@yahoo.com; 
tel: (66.02) 354.9145; 354.9146 ext. 18; fax: (+66.02) 354.9144
OPHELIA MENDOZA, MSPH, MStats, DrPH
Evaluation and Biostatistics Specialist
Training Consultant and Team Leader, Preventive Health System Support Project, Ministry of Health,
Vietnam & Asia Development Bank
Contact: email: opheliamendoza@yahoo.com; tel: (+63.2) 436.9332
CARIDAD A. ANCHETA, MD, MPH, PhD
Epidemiology and Biostatistics Specialist
Professor (retired), Department of Epidemiology and Biostatistics
College of Public Health, University of the Philippines Manila 
Contact: email: caancheta@yahoo.com
ORANUCH PACHUEN, BSN, MsPH DrPH
Public Health Specialist
Faculty of Public Health, Mahidol University
420/1 Ratchawithi Road, Rajthevee, Bangkok 10400, Thailand
Contact: email: phopc@mahidol.ac.th; tel/fax: (+66.02) 354.8555
Mobile phone: (+66.087) 687.6097
KERRY RICHTER, PhD
Qualitative Methods Specialist and Network Analysis
Institute for Population and Social Research
Mahidol University, Thailand
Contact: email: krichter99@gmail.com; tel: (+66.89) 215.2698 (mobile-Thailand);
or (+1.301) 979.9852 (U.S. number with voice mail); Skype: krichter99
MALEE SUNPUWAN, BSN, MA, PhD
Qualitative Methods Specialist
Lecturer: Institute for Population and Social Research, 
Mahidol University, Thailand
Contact: email: prmalee@staff2.mahidol.ac.th; tel: (66.02) 441.0201.4 ext. 268; 
Mobile phone: 66.81992 0252
ELAINE PEREZ
Data Manager
Research Specialist/Monitoring and Evaluation Assistant—SHIELD Project
Helen Keller International, Manila
Contact: email: eseducoperez@gmail.com
PRATAP SINGHASIVANON, MD, MPH, DrPH 
Advisor 
Dean, Faculty of Tropical Medicine, Mahidol University
Secretary General/Coordinator, SEAMEO TROPMED Network
Contact: email: psinghasivanon@gmail.com
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DSN Africa Evaluation Team Members—Swiss Tropical & Public Health Institute 
JAKOB ZINSSTAG, Professor, Dr. med. vet., PhD, Dip. ECVPH 
Project Leader
Head, Human and Animal Health Research Unit 
Dept. of Epidemiology and Public Health Unit 
Contact: email: Jakob.Zinsstag@unibas.ch; tel: 41.61.284.81.39
XAVIER BOSCH, MD, MSc
Senior Evaluator
Deputy Head, Systems Performance & Monitoring Unit 
Contact: email: X.Bosch@unibas.ch
BARBARA MATTHYS, PhD
Evaluator
Project Officer, Systems Performance & Monitoring
Contact: email: Barbara.Matthys@unibas.ch
LISA CRUMP, DVM
Junior Evaluator 
Project Assistant, Human and Animal Health Research Unit 
Dept. of Epidemiology and Public Health Unit 
Contact: email: Lisa.Crump@unibas.ch
DSN Africa Evaluation Team Members—Africa Population and Health Research Center 
REMARE ETTARH, PhD
Evaluator
Associate Research Scientist, Health Challenges and Systems
Contact: email: rettarh@aphrc.org; tel: +254.20.4001053
NELLY YATICH, PhD, MPH
Evaluator
Postdoctoral Fellow, Health Challenges and Systems
Contact: email: nyatich@aphrc.org
AKACO EKIRAPA, MSc
Junior Evaluator
Research Officer, Health Challenges and Systems
Contact: email: aekirapa@aphrc.org
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